European Association of Urology
Guidelines
Education & Events
Join our events Join our events
On-demand education Learn at your own pace
Scholarships Enrich your capabilities
Exchange Programmes Urology beyond Europe
Education Educational Platforms Talent Incubator Programme Accreditation
Science & Publications
Publications Our publications
Research & Science Passionate about research?
About
Who we are Our mission and history
Our Board and Offices How we work
Join the EAU Find out about membership
Vacancies Contact
Guidelines

Non-neurogenic Female LUTS

Want to read the guideline in your own time? Download the PDF

Download full guideline

Looking for a quick overview? Check the pocket guidelines.

Download pocket guidelines
Full text guidelineSummary of ChangesPublications & AppendicesPanelRelated content
No results found
  1. Introduction
  2. Methods
  3. Diagnosis
  4. Disease Management
  5. References
  6. Conflict Of Interest
  7. Citation Information
  8. Copyright And Terms Of Use
5. References
  • 1. Introduction
  • 2. Methods
  • 3. Diagnosis
  • 4. Disease Management
  • 5. References
  • 6. Conflict Of Interest
  • 7. Citation Information
  • 8. Copyright And Terms Of Use
  • No elements found. Consider changing the search query.
  • List is empty.

5. REFERENCES

1.Abrams, P., et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn, 2002. 21: 167.

https://www.ncbi.nlm.nih.gov/pubmed/11857671

2.Milsom, I., et al. Effect of bothersome overactive bladder symptoms on health-related quality of life, anxiety, depression, and treatment seeking in the United States: results from EpiLUTS. Urology, 2012. 80: 90.

https://www.ncbi.nlm.nih.gov/pubmed/22748867

3.Felde, G., et al. Anxiety and depression associated with urinary incontinence. A 10-year follow-up study from the Norwegian HUNT study (EPINCONT). Neurourol Urodyn, 2017. 36: 322.

https://www.ncbi.nlm.nih.gov/pubmed/26584597

4.Eapen, R.S., et al. Review of the epidemiology of overactive bladder. Res Rep Urol, 2016. 8: 71.

https://www.ncbi.nlm.nih.gov/pubmed/27350947

5.Coyne, K.S., et al. The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) study. BJU Int, 2009. 104: 352.

https://www.ncbi.nlm.nih.gov/pubmed/19281467

6.Coyne, K.S., et al. The burden of lower urinary tract symptoms: evaluating the effect of LUTS on health-related quality of life, anxiety and depression: EpiLUTS. BJU Int, 2009. 103 Suppl 3: 4.

https://www.ncbi.nlm.nih.gov/pubmed/19302497

7.Irwin, D.E., et al. The economic impact of overactive bladder syndrome in six Western countries. BJU Int, 2009. 103: 202.

https://www.ncbi.nlm.nih.gov/pubmed/19278532

8.EAU. An Urge to Act. 2024.

https://uroweb.org/an-urge-to-act

9.Abrams, P., et al. 5th International Consultation on Incontinence, Paris, February 2012.

https://www.ics.org/Publications/ICI_5/INCONTINENCE.pdf

10.Radmayr, C., Nijman, RJ., Stein, R., Tekgül, S. Dogan, S. et al. , EAU Guidelines on Paediatric Urology, in EAU Guidelines, . 2021, EAU Guidelines Office: Arnhem, the Netherlands.

https://uroweb.org/guidelines/paediatric-urology

11.Sartori, A.M., et al. Summary of the 2024 Update of the European Association of Urology Guidelines on Neurourology. Eur Urol, 2024. 85: 543.

https://www.ncbi.nlm.nih.gov/pubmed/38594103

12.Phillips, B., Ball, C., Sackett, D., Doug Badenoch, Sharon Straus, Brian Haynes, Martin Dawes since November 1998. . Oxford Centre for Evidence-Based Medicine: Levels of Evidence (March 2009). Updated by Jeremy Howick March 2009. 2009. 2020.

https://www.cebm.ox.ac.uk/resources/levels-of-evidence/oxford-centre-for-evidence-based-medicine-levels-of-evidence-march-2009

13.Guyatt, G.H., et al. Going from evidence to recommendations. BMJ, 2008. 336: 1049.

https://www.ncbi.nlm.nih.gov/pubmed/18467413

14.D'Ancona, C., et al. The International Continence Society (ICS) report on the terminology for adult male lower urinary tract and pelvic floor symptoms and dysfunction. Neurourol Urodyn, 2019. 38: 433.

https://www.ncbi.nlm.nih.gov/pubmed/30681183

15.Bonkat, G., Bartoletti, R., Bruyère, F., et al. , EAU Guidelines on Urological Infections. 2021, EAU Guidelines Office: Arnhem, The Netherlands.

https://uroweb.org/guidelines/urological-infections

16.Engeler, D., et al. EAU Guidelines on Chronic Pelvic Pain. Edn presented at the 37th EAU Annual Congress, Paris, 2021. Arnhem, the Netherlands.

https://uroweb.org/guidelines/chronic-pelvic-pain

17.U.S. Department of Health and Human Services, F.a.D.A. Guidance for Industry - Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. 2009. 2016.

https://www.fda.gov/media/77832/download

18.Malde, S., et al. Case-finding tools for the diagnosis of OAB in women: A narrative review. Neurourol Urodyn, 2020. 39: 13.

https://www.ncbi.nlm.nih.gov/pubmed/31578764

19.Chan, S.S., et al. Responsiveness of the Pelvic Floor Distress Inventory and Pelvic Floor Impact Questionnaire in women undergoing treatment for pelvic floor disorders. Int Urogynecol J, 2013. 24: 213.

https://www.ncbi.nlm.nih.gov/pubmed/22669425

20.Kim, J., et al. 1576 Is there a relationship between incontinence impact questionnaire 7 score after surgery for stress urinary incontinence and patient-perceived satisfaction and improvement? Journal of Urology, 2013. 189: e647.

https://doi.org/10.1016/j.juro.2013.02.3126

21.Wuytack, F., et al. A systematic review of utility-based and disease-specific quality of life measurement instruments for women with urinary incontinence. Neurourol Urodyn, 2021. 40: 1275.

https://www.ncbi.nlm.nih.gov/pubmed/34082483

22.Cardoze, L., et al., Incontinence 7th Edition 2023, Bristol, UK.

https://www.ics.org/ici

23.Shy, M., et al. Objective Evaluation of Overactive Bladder: Which Surveys Should I Use? Curr Bladder Dysfunct Rep, 2013. 8: 45.

https://www.ncbi.nlm.nih.gov/pubmed/23439804

24.Haylen, B.T., et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint terminology and classification of the complications related directly to the insertion of prostheses (meshes, implants, tapes) and grafts in female pelvic floor surgery. Neurourol Urodyn, 2011. 30: 2.

https://www.ncbi.nlm.nih.gov/pubmed/21181958

25.Brown, J.S., et al. Measurement characteristics of a voiding diary for use by men and women with overactive bladder. Urology, 2003. 61: 802.

https://www.ncbi.nlm.nih.gov/pubmed/12670569

26.Nygaard, I., et al. Reproducibility of the seven-day voiding diary in women with stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct, 2000. 11: 15.

https://www.ncbi.nlm.nih.gov/pubmed/10738929

27.Bright, E., et al. Developing and validating the International Consultation on Incontinence Questionnaire bladder diary. Eur Urol, 2014. 66: 294.

https://www.ncbi.nlm.nih.gov/pubmed/24647230

28.Jimenez-Cidre, M.A., et al. The 3-day bladder diary is a feasible, reliable and valid tool to evaluate the lower urinary tract symptoms in women. Neurourol Urodyn, 2015. 34: 128.

https://www.ncbi.nlm.nih.gov/pubmed/24264859

29.Ertberg, P., et al. A comparison of three methods to evaluate maximum bladder capacity: cystometry, uroflowmetry and a 24-h voiding diary in women with urinary incontinence. Acta Obstet Gynecol Scand, 2003. 82: 374.

https://www.ncbi.nlm.nih.gov/pubmed/12716323

30.Fitzgerald, M.P., et al. Variability of 24-hour voiding diary variables among asymptomatic women. J Urol, 2003. 169: 207.

https://www.ncbi.nlm.nih.gov/pubmed/12478137

31.Burgio, K.L., et al. Behavioral vs drug treatment for urge urinary incontinence in older women: a randomized controlled trial. JAMA, 1998. 280: 1995.

https://www.ncbi.nlm.nih.gov/pubmed/9863850

32.Fayyad, A.M., et al. Urine production and bladder diary measurements in women with type 2 diabetes mellitus and their relation to lower urinary tract symptoms and voiding dysfunction. Neurourol Urodyn, 2010. 29: 354.

https://www.ncbi.nlm.nih.gov/pubmed/19760759

33.Homma, Y., et al. Assessment of overactive bladder symptoms: comparison of 3-day bladder diary and the overactive bladder symptoms score. Urology, 2011. 77: 60.

https://www.ncbi.nlm.nih.gov/pubmed/20951412

34.Stav, K., et al. Women overestimate daytime urinary frequency: the importance of the bladder diary. J Urol, 2009. 181: 2176.

https://www.ncbi.nlm.nih.gov/pubmed/19296975

35.van Brummen, H.J., et al. The association between overactive bladder symptoms and objective parameters from bladder diary and filling cystometry. Neurourol Urodyn, 2004. 23: 38.

https://www.ncbi.nlm.nih.gov/pubmed/14694455

36.Yap, T.L., et al. A systematic review of the reliability of frequency-volume charts in urological research and its implications for the optimum chart duration. BJU Int, 2007. 99: 9.

https://www.ncbi.nlm.nih.gov/pubmed/16956355

37.Bright, E., et al. Urinary diaries: evidence for the development and validation of diary content, format, and duration. Neurourol Urodyn, 2011. 30: 348.

https://www.ncbi.nlm.nih.gov/pubmed/21284023

38.Buchsbaum, G.M., et al. Utility of urine reagent strip in screening women with incontinence for urinary tract infection. Int Urogynecol J Pelvic Floor Dysfunct, 2004. 15: 391.

https://www.ncbi.nlm.nih.gov/pubmed/15278254

39.Arinzon, Z., et al. Clinical presentation of urinary tract infection (UTI) differs with aging in women. Arch Gerontol Geriatr, 2012. 55: 145.

https://www.ncbi.nlm.nih.gov/pubmed/21963175

40.Moore, E.E., et al. Urinary incontinence and urinary tract infection: temporal relationships in postmenopausal women. Obstet Gynecol, 2008. 111: 317.

https://www.ncbi.nlm.nih.gov/pubmed/18238968

41.Ouslander, J.G., et al. Does eradicating bacteriuria affect the severity of chronic urinary incontinence in nursing home residents? Ann Intern Med, 1995. 122: 749.

https://www.ncbi.nlm.nih.gov/pubmed/7717597

42.Griffiths, D.J., et al. Variability of post-void residual urine volume in the elderly. Urol Res, 1996. 24: 23.

https://www.ncbi.nlm.nih.gov/pubmed/8966837

43.Marks, L.S., et al. Three-dimensional ultrasound device for rapid determination of bladder volume. Urology, 1997. 50: 341.

https://www.ncbi.nlm.nih.gov/pubmed/9301695

44.Nygaard, I.E. Postvoid residual volume cannot be accurately estimated by bimanual examination. Int Urogynecol J Pelvic Floor Dysfunct, 1996. 7: 74.

https://www.ncbi.nlm.nih.gov/pubmed/8798090

45.Ouslander, J.G., et al. Use of a portable ultrasound device to measure post-void residual volume among incontinent nursing home residents. J Am Geriatr Soc, 1994. 42: 1189.

https://www.ncbi.nlm.nih.gov/pubmed/7963206

46.Stoller, M.L., et al. The accuracy of a catheterized residual urine. J Urol, 1989. 141: 15.

https://www.ncbi.nlm.nih.gov/pubmed/2908944

47.Robinson, D., et al. Defining female voiding dysfunction: ICI-RS 2011. Neurourol Urodyn, 2012. 31: 313.

https://www.ncbi.nlm.nih.gov/pubmed/22415792

48.Gehrich, A., et al. Establishing a mean postvoid residual volume in asymptomatic perimenopausal and postmenopausal women. Obstet Gynecol, 2007. 110: 827.

https://www.ncbi.nlm.nih.gov/pubmed/17906016

49.Haylen, B.T., et al. Immediate postvoid residual volumes in women with symptoms of pelvic floor dysfunction. Obstet Gynecol, 2008. 111: 1305.

https://www.ncbi.nlm.nih.gov/pubmed/18515513

50.Lukacz, E.S., et al. Elevated postvoid residual in women with pelvic floor disorders: prevalence and associated risk factors. Int Urogynecol J Pelvic Floor Dysfunct, 2007. 18: 397.

https://www.ncbi.nlm.nih.gov/pubmed/16804634

51.Milleman, M., et al. Post-void residual urine volume in women with overactive bladder symptoms. J Urol, 2004. 172: 1911.

https://www.ncbi.nlm.nih.gov/pubmed/15540753

52.Tseng, L.H., et al. Postvoid residual urine in women with stress incontinence. Neurourol Urodyn, 2008. 27: 48.

https://www.ncbi.nlm.nih.gov/pubmed/17563112

53.Abrams, P. Bladder outlet obstruction index, bladder contractility index and bladder voiding efficiency: three simple indices to define bladder voiding function. BJU Int, 1999. 84: 14.

https://www.ncbi.nlm.nih.gov/pubmed/10444116

54.Rosier, P.F.W.M., Kuo, H-C,, Finazzi Agro, E., De Gennaro. M., Gammie, A., Kakizaki, H,, Hashim, H., Toozs-Hobson, P., Committee 6. Urodynamic testing, in Incontinence, P. Abrams, Cardozo, L., Wagg, A, Wein, A. , Editor. 2017, CI-ICS. International Continence Society: Bristol UK.

https://www.ics.org/Publications/ICI_5/INCONTINENCE.pdf

55.Siroky, M.B., et al. The flow rate nomogram: I. Development. J Urol, 1979. 122: 665.

https://www.ncbi.nlm.nih.gov/pubmed/159366

56.Haylen, B.T., et al. Maximum and average urine flow rates in normal male and female populations--the Liverpool nomograms. Br J Urol, 1989. 64: 30.

https://www.ncbi.nlm.nih.gov/pubmed/2765766

57.Rosier, P., et al. International Continence Society Good Urodynamic Practices and Terms 2016: Urodynamics, uroflowmetry, cystometry, and pressure-flow study. Neurourol Urodyn, 2017. 36: 1243.

https://www.ncbi.nlm.nih.gov/pubmed/27917521

58.Working Group of the United Kingdom Continence, S., et al. United Kingdom Continence Society: Minimum standards for urodynamic studies, 2018. Neurourol Urodyn, 2019. 38: 838.

https://www.ncbi.nlm.nih.gov/pubmed/30648750

59.Dorflinger, A., et al. Urethral pressure profile: is it affected by position? Neurourol Urodyn, 2002. 21: 553.

https://www.ncbi.nlm.nih.gov/pubmed/12382246

60.Wang, A.C., et al. A comparison of urethral pressure profilometry using microtip and double-lumen perfusion catheters in women with genuine stress incontinence. BJOG, 2002. 109: 322.

https://www.ncbi.nlm.nih.gov/pubmed/11950188

61.NICE. NICE Guidance - Urinary incontinence and pelvic organ prolapse in women: management: (c) NICE (2019) Urinary incontinence and pelvic organ prolapse in women: management. BJU Int, 2019. 123: 777.

https://www.ncbi.nlm.nih.gov/pubmed/31008559

62.van Leijsen, S.A., et al. The correlation between clinical and urodynamic diagnosis in classifying the type of urinary incontinence in women. A systematic review of the literature. Neurourol Urodyn, 2011. 30: 495.

https://www.ncbi.nlm.nih.gov/pubmed/21298721

63.Schick, E., et al. Predictive value of maximum urethral closure pressure, urethral hypermobility and urethral incompetence in the diagnosis of clinically significant female genuine stress incontinence. J Urol, 2004. 171: 1871.

https://www.ncbi.nlm.nih.gov/pubmed/15076296

64.Albo, M.E., et al. Burch colposuspension versus fascial sling to reduce urinary stress incontinence. N Engl J Med, 2007. 356: 2143.

https://www.ncbi.nlm.nih.gov/pubmed/17517855

65.Klarskov, N. Urethral pressure reflectometry. A method for simultaneous measurements of pressure and cross-sectional area in the female urethra. Dan Med J, 2012. 59: B4412.

https://www.ncbi.nlm.nih.gov/pubmed/22381095

66.Dokmeci, F., et al. Comparison of ambulatory versus conventional urodynamics in females with urinary incontinence. Neurourol Urodyn, 2010. 29: 518.

https://www.ncbi.nlm.nih.gov/pubmed/19731314

67.Radley, S.C., et al. Conventional and ambulatory urodynamic findings in women with symptoms suggestive of bladder overactivity. J Urol, 2001. 166: 2253.

https://www.ncbi.nlm.nih.gov/pubmed/11696746

68.Pang, K.H., et al. Diagnostic Tests for Female Bladder Outlet Obstruction: A Systematic Review from the European Association of Urology Non-neurogenic Female LUTS Guidelines Panel. Eur Urol Focus, 2022. 8: 1015.

https://www.ncbi.nlm.nih.gov/pubmed/34538750

69.Rademakers, K., et al. Recommendations for future development of contractility and obstruction nomograms for women. ICI-RS 2014. Neurourol Urodyn, 2016. 35: 307.

https://www.ncbi.nlm.nih.gov/pubmed/26872573

70.Osman, N.I., et al. Detrusor underactivity and the underactive bladder: a new clinical entity? A review of current terminology, definitions, epidemiology, aetiology, and diagnosis. Eur Urol, 2014. 65: 389.

https://www.ncbi.nlm.nih.gov/pubmed/24184024

71.Nitti, V.W., et al. Diagnosing bladder outlet obstruction in women. J Urol, 1999. 161: 1535.

https://www.ncbi.nlm.nih.gov/pubmed/10210391

72.Clement, K.D., et al. Urodynamic studies for management of urinary incontinence in children and adults. Cochrane Database Syst Rev, 2013. 2013: CD003195.

https://www.ncbi.nlm.nih.gov/pubmed/24166676

73.Bodmer, N.S., et al. Randomised Controlled Trials Assessing the Clinical Value of Urodynamic Studies: A Systematic Review and Meta-analysis. Eur Urol Open Sci, 2022. 44: 131.

https://www.ncbi.nlm.nih.gov/pubmed/36110903

74.Rachaneni, S., et al. Does preoperative urodynamics improve outcomes for women undergoing surgery for stress urinary incontinence? A systematic review and meta-analysis. BJOG, 2015. 122: 8.

https://www.ncbi.nlm.nih.gov/pubmed/25041381

75.Nager, C.W., et al. A randomized trial of urodynamic testing before stress-incontinence surgery. N Engl J Med, 2012. 366: 1987.

https://www.ncbi.nlm.nih.gov/pubmed/22551104

76.Serati, M., et al. Urodynamics useless before surgery for female stress urinary incontinence: Are you sure? Results from a multicenter single nation database. Neurourol Urodyn, 2016. 35: 809.

https://www.ncbi.nlm.nih.gov/pubmed/26061435

77.Abdel-Fattah, M., et al. Female Urgency, Trial of Urodynamics as Routine Evaluation (FUTURE study): a superiority randomised clinical trial to evaluate the effectiveness and cost-effectiveness of invasive urodynamic investigations in management of women with refractory overactive bladder symptoms. Trials, 2021. 22: 745.

https://www.ncbi.nlm.nih.gov/pubmed/34702331

78.Gravas, S., et al., EAU Guidelines on the management of Non-Neurogenice Male LUTS, in EAU Guidelines. Edn. published at the 37th EAU Annual Congress, Paris, E.G. Office, Editor. 2021, EAU Guidelines Office Arnhem, The Netherlands.

https://uroweb.org/guidelines/management-of-non-neurogenic-male-luts

79.Nager, C.W., et al. Baseline urodynamic predictors of treatment failure 1 year after mid urethral sling surgery. J Urol, 2011. 186: 597.

https://www.ncbi.nlm.nih.gov/pubmed/21683412

80.Lin, F.C., et al. The Role of Urodynamic Testing Prior to Third-Line OAB Therapy. Current Bladder Dysfunction Reports, 2020. 15: 159.

https://doi.org/10.1007/s11884-020-00587-z

81.Nitti, V.W., et al. Response to fesoterodine in patients with an overactive bladder and urgency urinary incontinence is independent of the urodynamic finding of detrusor overactivity. BJU Int, 2010. 105: 1268.

https://www.ncbi.nlm.nih.gov/pubmed/19889062

82.Dawson, T., et al. Factors predictive of post-TVT voiding dysfunction. Int Urogynecol J Pelvic Floor Dysfunct, 2007. 18: 1297.

https://www.ncbi.nlm.nih.gov/pubmed/17347790

83.Hong, B., et al. Factors predictive of urinary retention after a tension-free vaginal tape procedure for female stress urinary incontinence. J Urol, 2003. 170: 852.

https://www.ncbi.nlm.nih.gov/pubmed/12913715

84.Miller, E.A., et al. Preoperative urodynamic evaluation may predict voiding dysfunction in women undergoing pubovaginal sling. J Urol, 2003. 169: 2234.

https://www.ncbi.nlm.nih.gov/pubmed/12771757

85.Groen, J., et al. Bladder contraction strength parameters poorly predict the necessity of long-term catheterization after a pubovaginal rectus fascial sling procedure. J Urol, 2004. 172: 1006.

https://www.ncbi.nlm.nih.gov/pubmed/15311024

86.Abdel-Fattah, M., et al. Pelvicol pubovaginal sling versus tension-free vaginal tape for treatment of urodynamic stress incontinence: a prospective randomized three-year follow-up study. Eur Urol, 2004. 46: 629.

https://www.ncbi.nlm.nih.gov/pubmed/15474274

87.Lemack, G.E., et al. Normal preoperative urodynamic testing does not predict voiding dysfunction after Burch colposuspension versus pubovaginal sling. J Urol, 2008. 180: 2076.

https://www.ncbi.nlm.nih.gov/pubmed/18804239

88.Al Afraa, T., et al. Normal lower urinary tract assessment in women: I. Uroflowmetry and post-void residual, pad tests, and bladder diaries. Int Urogynecol J, 2012. 23: 681.

https://www.ncbi.nlm.nih.gov/pubmed/21935667

89.Krhut, J., et al. Pad weight testing in the evaluation of urinary incontinence. Neurourol Urodyn, 2014. 33: 507.

https://www.ncbi.nlm.nih.gov/pubmed/23797972

90.Medeiros Araujo, C., et al. Pad test for urinary incontinence diagnosis in adults: Systematic review of diagnostic test accuracy. Neurourol Urodyn, 2022. 41: 696.

https://www.ncbi.nlm.nih.gov/pubmed/35114027

91.Fajar Marta, K., et al. Level of agreement and acceptance of the 20-Minute versus 60-Minute sanitary pad test as a method for measuring the severity of stress urinary incontinence: randomised crossover trial. J Obstet Gynaecol, 2022. 42: 1251.

https://www.ncbi.nlm.nih.gov/pubmed/34558386

92.Painter, V., et al. Does patient activity level affect 24-hr pad test results in stress-incontinent women? Neurourol Urodyn, 2012. 31: 143.

https://www.ncbi.nlm.nih.gov/pubmed/21780173

93.Costantini, E., et al. Sensitivity and specificity of one-hour pad test as a predictive value for female urinary incontinence. Urol Int, 2008. 81: 153.

https://www.ncbi.nlm.nih.gov/pubmed/18758212

94.Richter, H.E., et al. Demographic and clinical predictors of treatment failure one year after midurethral sling surgery. Obstet Gynecol, 2011. 117: 913.

https://www.ncbi.nlm.nih.gov/pubmed/21422865

95.Ward, K.L., et al. A prospective multicenter randomized trial of tension-free vaginal tape and colposuspension for primary urodynamic stress incontinence: two-year follow-up. Am J Obstet Gynecol, 2004. 190: 324.

https://www.ncbi.nlm.nih.gov/pubmed/14981369

96.Lose, G., et al. Pad-weighing test performed with standardized bladder volume. Urology, 1988. 32: 78.

https://www.ncbi.nlm.nih.gov/pubmed/3388665

97.Tubaro, A., et al., Committee 7 Imaging, neurophysiological testing and other tests, in Incontinence P. Abrams, Cardozo, L., Wagg, A., Wein, A. , Editor. 2017, ICI-ICS. International Continence Society: Bristol, UK.

https://www.ics.org/Publications/ICI_5/INCONTINENCE.pdf

98.Deng, S., et al. ROC Analysis and Significance of Transperineal Ultrasound in the Diagnosis of Stress Urinary Incontinence. Journal of Medical Imaging and Health Informatics, 2020. 10: 113.

https://doi.org/10.1166/jmihi.2020.2864

99.Keshavarz, E., et al. Prediction of Stress Urinary Incontinence Using the Retrovesical (beta) Angle in Transperineal Ultrasound. J Ultrasound Med, 2021. 40: 1485.

https://www.ncbi.nlm.nih.gov/pubmed/33035377

100.Illiano, E., et al. Translabial ultrasound: a non-invasive technique for assessing "technical errors" after TOT failure. Int Urogynecol J, 2022. 33: 1023.

https://www.ncbi.nlm.nih.gov/pubmed/34191103

101.Antunes-Lopes, T., et al. Biomarkers in lower urinary tract symptoms/overactive bladder: a critical overview. Curr Opin Urol, 2014. 24: 352.

https://www.ncbi.nlm.nih.gov/pubmed/24841379

102.Lekskulchai, O., et al. Is detrusor hypertrophy in women associated with voiding dysfunction? Aust N Z J Obstet Gynaecol, 2009. 49: 653.

https://www.ncbi.nlm.nih.gov/pubmed/20070717

103.Woodfield, C.A., et al. Imaging pelvic floor disorders: trend toward comprehensive MRI. AJR Am J Roentgenol, 2010. 194: 1640.

https://www.ncbi.nlm.nih.gov/pubmed/20489108

104.Lockhart, M.E., et al. Reproducibility of dynamic MR imaging pelvic measurements: a multi-institutional study. Radiology, 2008. 249: 534.

https://www.ncbi.nlm.nih.gov/pubmed/18796659

105.Shek, K.L., et al. The urethral motion profile before and after suburethral sling placement. J Urol, 2010. 183: 1450.

https://www.ncbi.nlm.nih.gov/pubmed/20171657

106.Chantarasorn, V., et al. Sonographic appearance of transobturator slings: implications for function and dysfunction. Int Urogynecol J, 2011. 22: 493.

https://www.ncbi.nlm.nih.gov/pubmed/20967418

107.Bile Silva, A., et al. Systematic review of urinary biomarkers of female bladder outlet obstruction (fBOO). Arch Ital Urol Androl, 2022. 94: 355.

https://www.ncbi.nlm.nih.gov/pubmed/36165485

108.Mossa, A.H., et al. Urinary metabolomics predict the severity of overactive bladder syndrome in an aging female population. Int Urogynecol J, 2020. 31: 1023.

https://www.ncbi.nlm.nih.gov/pubmed/31813035

109.Govender, Y., et al. The Current Evidence on the Association Between the Urinary Microbiome and Urinary Incontinence in Women. Front Cell Infect Microbiol, 2019. 9: 133.

https://www.ncbi.nlm.nih.gov/pubmed/31119104

110.Haylen, B.T., et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn, 2010. 29: 4.

https://www.ncbi.nlm.nih.gov/pubmed/19941278

111.Irwin, D.E., et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol, 2006. 50: 1306.

https://www.ncbi.nlm.nih.gov/pubmed/17049716

112.Tsiapakidou, S., et al. The use of urinary biomarkers in the diagnosis of overactive bladder in female patients. A systematic review and meta-analysis. Int Urogynecol J, 2021. 32: 3143.

https://www.ncbi.nlm.nih.gov/pubmed/34363496

113.Cameron, A.P., et al. The AUA/SUFU guideline on the diagnosis and treatment of idiopathic overactive bladder. Neurourol Urodyn, 2024. 43: 1742.

https://www.ncbi.nlm.nih.gov/pubmed/39010271

114.Sarma, A.V., et al. Risk factors for urinary incontinence among women with type 1 diabetes: findings from the epidemiology of diabetes interventions and complications study. Urology, 2009. 73: 1203.

https://www.ncbi.nlm.nih.gov/pubmed/19362350

115.Ertas, K., et al. Effect of combined use of tolterodine and continuous positive airway pressure vs continuous positive airway pressure only treatment on overactive bladder symptoms in women with moderate-to-severe obstructive sleep apnea syndrome: a randomized clinical trial. Int Urogynecol J, 2022. 33: 2031.

https://www.ncbi.nlm.nih.gov/pubmed/35445808

116.Geng, V., et al., Catheterisation Indwelling catheters in adults – Urethral and Suprapubic - Evidence-based Guidelines for Best Practice in Urological Health Care. 2012 ed, ed. E.A.o.U. Nurses. 2012.

https://nurses.uroweb.org/guideline/indwelling-catheterisation-in-adults-urethral-and-suprapubic/

117.Brazzelli, M., et al. Absorbent products for containing urinary and/or fecal incontinence in adults. J Wound Ostomy Continence Nurs, 2002. 29: 45.

https://www.ncbi.nlm.nih.gov/pubmed/11810074

118.Fader, M., et al. Absorbent products for urinary/faecal incontinence: a comparative evaluation of key product designs. Health Technol Assess, 2008. 12: iii.

https://www.ncbi.nlm.nih.gov/pubmed/18547500

119.Jahn, P., et al. Types of indwelling urinary catheters for long-term bladder drainage in adults. Cochrane Database Syst Rev, 2012. 10: CD004997.

https://www.ncbi.nlm.nih.gov/pubmed/23076911

120.Hunter, K.F., et al. Long-term bladder drainage: Suprapubic catheter versus other methods: a scoping review. Neurourol Urodyn, 2013. 32: 944.

https://www.ncbi.nlm.nih.gov/pubmed/23192860

121.Niel-Weise, B.S., et al. Urinary catheter policies for long-term bladder drainage. Cochrane Database Syst Rev, 2012: CD004201.

https://www.ncbi.nlm.nih.gov/pubmed/22895939

122.Fisher, H., et al. Continuous low-dose antibiotic prophylaxis for adults with repeated urinary tract infections (AnTIC): a randomised, open-label trial. Lancet Infect Dis, 2018. 18: 957.

https://www.ncbi.nlm.nih.gov/pubmed/30037647

123.Tauzin-Fin, P., et al. Sublingual oxybutynin reduces postoperative pain related to indwelling bladder catheter after radical retropubic prostatectomy. Br J Anaesth, 2007. 99: 572.

https://www.ncbi.nlm.nih.gov/pubmed/17681969

124.Agarwal, A., et al. The efficacy of tolterodine for prevention of catheter-related bladder discomfort: a prospective, randomized, placebo-controlled, double-blind study. Anesth Analg, 2005. 101: 1065.

https://www.ncbi.nlm.nih.gov/pubmed/16192522

125.Chung, J.M., et al. Evaluation of the Efficacy of Solifenacin for Preventing Catheter-Related Bladder Discomfort After Transurethral Resection of Bladder Tumors in Patients With Non-Muscle Invasive Bladder Cancer: A Prospective, Randomized, Multicenter Study. Clin Genitourin Cancer, 2017. 15: 157.

https://www.ncbi.nlm.nih.gov/pubmed/27346074

126.Tijani, K.H., et al. Role of tolterodine in the management of postoperative catheter-related bladder discomfort: Findings in a Nigerian teaching hospital. Niger J Clin Pract, 2017. 20: 484.

https://www.ncbi.nlm.nih.gov/pubmed/28406132

127.Le Berre, M., et al. What do we really know about the role of caffeine on urinary tract symptoms? A scoping review on caffeine consumption and lower urinary tract symptoms in adults. Neurourol Urodyn, 2020. 39: 1217.

https://www.ncbi.nlm.nih.gov/pubmed/32270903

128.Swithinbank, L., et al. The effect of fluid intake on urinary symptoms in women. J Urol, 2005. 174: 187.

https://www.ncbi.nlm.nih.gov/pubmed/15947624

129.Dowd, T.T., et al. Fluid intake and urinary incontinence in older community-dwelling women. J Community Health Nurs, 1996. 13: 179.

https://www.ncbi.nlm.nih.gov/pubmed/8916607

130.Hashim, H., et al. How should patients with an overactive bladder manipulate their fluid intake? BJU Int, 2008. 102: 62.

https://www.ncbi.nlm.nih.gov/pubmed/18284414

131.Zimmern, P., et al. Effect of fluid management on fluid intake and urge incontinence in a trial for overactive bladder in women. BJU Int, 2010. 105: 1680.

https://www.ncbi.nlm.nih.gov/pubmed/19912207

132.Hunskaar, S. A systematic review of overweight and obesity as risk factors and targets for clinical intervention for urinary incontinence in women. Neurourol Urodyn, 2008. 27: 749.

https://www.ncbi.nlm.nih.gov/pubmed/18951445

133.Subak, L.L., et al. Weight loss to treat urinary incontinence in overweight and obese women. N Engl J Med, 2009. 360: 481.

https://www.ncbi.nlm.nih.gov/pubmed/19179316

134.Chen, C.C., et al. Obesity is associated with increased prevalence and severity of pelvic floor disorders in women considering bariatric surgery. Surg Obes Relat Dis, 2009. 5: 411.

https://www.ncbi.nlm.nih.gov/pubmed/19136310

135.Hannestad, Y.S., et al. Are smoking and other lifestyle factors associated with female urinary incontinence? The Norwegian EPINCONT Study. BJOG, 2003. 110: 247.

https://www.ncbi.nlm.nih.gov/pubmed/12628262

136.Danforth, K.N., et al. Risk factors for urinary incontinence among middle-aged women. Am J Obstet Gynecol, 2006. 194: 339.

https://www.ncbi.nlm.nih.gov/pubmed/16458626

137.Imamura, M., et al. Systematic review and economic modelling of the effectiveness and cost-effectiveness of non-surgical treatments for women with stress urinary incontinence. Health Technol Assess, 2010. 14: 1.

https://www.ncbi.nlm.nih.gov/pubmed/20738930

138.Eustice, S., et al. Prompted voiding for the management of urinary incontinence in adults. Cochrane Database Syst Rev, 2000. 2000: CD002113.

https://www.ncbi.nlm.nih.gov/pubmed/10796861

139.Ostaszkiewicz, J., et al. Habit retraining for the management of urinary incontinence in adults. Cochrane Database Syst Rev, 2004. 2004: CD002801.

https://www.ncbi.nlm.nih.gov/pubmed/15106179

140.Rai, B.P., et al. Anticholinergic drugs versus non-drug active therapies for non-neurogenic overactive bladder syndrome in adults. Cochrane Database Syst Rev, 2012. 12: CD003193.

https://www.ncbi.nlm.nih.gov/pubmed/23235594

141.Reisch, B., et al. Cognitive components of behavioral therapy for overactive bladder: a systematic review. Int Urogynecol J, 2021. 32: 2619.

https://www.ncbi.nlm.nih.gov/pubmed/33609161

142.Steenstrup, B., et al. Cognitive-behavioral therapy and urge urinary incontinence in women. A systematic review. Int Urogynecol J, 2022. 33: 1091.

https://www.ncbi.nlm.nih.gov/pubmed/34716765

143.Shafik, A., et al. Overactive bladder inhibition in response to pelvic floor muscle exercises. World J Urol, 2003. 20: 374.

https://www.ncbi.nlm.nih.gov/pubmed/12682771

144.Bo, K., et al. Is pelvic floor muscle training effective for symptoms of overactive bladder in women? A systematic review. Physiotherapy, 2020. 106: 65.

https://www.ncbi.nlm.nih.gov/pubmed/32026847

145.Stewart, F., et al. Electrical stimulation with non-implanted electrodes for overactive bladder in adults. Cochrane Database Syst Rev, 2016. 12: CD010098.

https://www.ncbi.nlm.nih.gov/pubmed/27935011

146.Zomkowski, K., et al. The effectiveness of different electrical nerve stimulation protocols for treating adults with non-neurogenic overactive bladder: a systematic review and meta-analysis. Int Urogynecol J, 2022. 33: 1045.

https://www.ncbi.nlm.nih.gov/pubmed/35119495

147.Huang, J., et al. Comparative Efficacy of Neuromodulation Technologies for Overactive Bladder in Adults: A Network Meta-Analysis of Randomized Controlled Trials. Neuromodulation, 2023. 26: 1535.

https://www.ncbi.nlm.nih.gov/pubmed/35989159

148.Peyronnet, B., et al. Benefits and Harms of Conservative, Pharmacological, and Surgical Management Options for Women with Bladder Outlet Obstruction: A Systematic Review from the European Association of Urology Non-neurogenic Female LUTS Guidelines Panel. Eur Urol Focus, 2022. 8: 1340.

https://www.ncbi.nlm.nih.gov/pubmed/34702649

149.Sonmez, R., et al. Efficacy of percutaneous and transcutaneous tibial nerve stimulation in women with idiopathic overactive bladder: A prospective randomised controlled trial. Ann Phys Rehabil Med, 2022. 65: 101486.

https://www.ncbi.nlm.nih.gov/pubmed/33429090

150.Peters, K.M., et al. Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial. J Urol, 2009. 182: 1055.

https://www.ncbi.nlm.nih.gov/pubmed/19616802

151.Peters, K.M., et al. Percutaneous tibial nerve stimulation for the long-term treatment of overactive bladder: 3-year results of the STEP study. J Urol, 2013. 189: 2194.

https://www.ncbi.nlm.nih.gov/pubmed/23219541

152.Ghavidel-Sardsahra, A., et al. Efficacy of percutaneous and transcutaneous posterior tibial nerve stimulation on idiopathic overactive bladder and interstitial cystitis/painful bladder syndrome: A systematic review and meta-analysis. Neurourol Urodyn, 2022. 41: 539.

https://www.ncbi.nlm.nih.gov/pubmed/35032328

153.Finazzi-Agro, E., et al. Percutaneous tibial nerve stimulation effects on detrusor overactivity incontinence are not due to a placebo effect: a randomized, double-blind, placebo controlled trial. J Urol, 2010. 184: 2001.

https://www.ncbi.nlm.nih.gov/pubmed/20850833

154.Peters, K.M., et al. Randomized trial of percutaneous tibial nerve stimulation versus Sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT trial. J Urol, 2010. 183: 1438.

https://www.ncbi.nlm.nih.gov/pubmed/20171677

155.Wang, M., et al. Percutaneous tibial nerve stimulation for overactive bladder syndrome: a systematic review and meta-analysis. Int Urogynecol J, 2020. 31: 2457.

https://www.ncbi.nlm.nih.gov/pubmed/32681345

156.Farag, F., et al. What Are the Short-term Benefits and Potential Harms of Therapeutic Modalities for the Management of Overactive Bladder Syndrome in Women? A Review of Evidence Under the Auspices of the European Association of Urology, Female Non-neurogenic Lower Urinary Tract Symptoms Guidelines Panel. Eur Urol, 2023. 84: 302.

https://www.ncbi.nlm.nih.gov/pubmed/37331921

157.Booth, J., et al. The effectiveness of transcutaneous tibial nerve stimulation (TTNS) for adults with overactive bladder syndrome: A systematic review. Neurourol Urodyn, 2018. 37: 528.

https://www.ncbi.nlm.nih.gov/pubmed/28731583

158.Schreiner, L., et al. Randomized trial of transcutaneous tibial nerve stimulation to treat urge urinary incontinence in older women. Int Urogynecol J, 2010. 21: 1065.

https://www.ncbi.nlm.nih.gov/pubmed/20458465

159.Hargreaves, E., et al. Acupuncture for treating overactive bladder in adults. Cochrane Database Syst Rev, 2022. 9: CD013519.

https://www.ncbi.nlm.nih.gov/pubmed/36148895

160.Stoniute, A., et al. Oral anticholinergic drugs versus placebo or no treatment for managing overactive bladder syndrome in adults. Cochrane Database Syst Rev, 2023. 5: CD003781.

https://www.ncbi.nlm.nih.gov/pubmed/37160401

161.Herbison, P., et al. Which anticholinergic is best for people with overactive bladders? A network meta-analysis. Neurourol Urodyn, 2019. 38: 525.

https://www.ncbi.nlm.nih.gov/pubmed/30575999

162.Buser, N., et al. Efficacy and adverse events of antimuscarinics for treating overactive bladder: network meta-analyses. Eur Urol, 2012. 62: 1040.

https://www.ncbi.nlm.nih.gov/pubmed/22999811

163.Shamliyan, T., et al. Benefits and harms of pharmacologic treatment for urinary incontinence in women: a systematic review. Ann Intern Med, 2012. 156: 861.

https://www.ncbi.nlm.nih.gov/pubmed/22711079

164.Goldfischer, E.R., et al. Efficacy and safety of oxybutynin topical gel 3% in patients with urgency and/or mixed urinary incontinence: a randomized, double-blind, placebo-controlled study. Neurourol Urodyn, 2015. 34: 37.

https://www.ncbi.nlm.nih.gov/pubmed/24133005

165.Mostafaei, H., et al. Choosing the Most Efficacious and Safe Oral Treatment for Idiopathic Overactive Bladder: A Systematic Review and Network Meta-analysis. Eur Urol Focus, 2022. 8: 1072.

https://www.ncbi.nlm.nih.gov/pubmed/34563481

166.Nazir, J., et al. Comparative efficacy and tolerability of solifenacin 5 mg/day versus other oral antimuscarinic agents in overactive bladder: A systematic literature review and network meta-analysis. Neurourol Urodyn, 2018. 37: 986.

https://www.ncbi.nlm.nih.gov/pubmed/29140559

167.McDonagh, M.S., et al., in Drug Class Review: Agents for Overactive Bladder: Final Report Update 4. 2009: Portland (OR).

https://www.ncbi.nlm.nih.gov/pubmed/21089246

168.Novara, G., et al. A systematic review and meta-analysis of randomized controlled trials with antimuscarinic drugs for overactive bladder. Eur Urol, 2008. 54: 740.

https://www.ncbi.nlm.nih.gov/pubmed/18632201

169.Chapple, C., et al. Clinical efficacy, safety, and tolerability of once-daily fesoterodine in subjects with overactive bladder. Eur Urol, 2007. 52: 1204.

https://www.ncbi.nlm.nih.gov/pubmed/17651893

170.Herschorn, S., et al. Comparison of fesoterodine and tolterodine extended release for the treatment of overactive bladder: a head-to-head placebo-controlled trial. BJU Int, 2010. 105: 58.

https://www.ncbi.nlm.nih.gov/pubmed/20132103

171.DuBeau, C.E., et al. Efficacy and tolerability of fesoterodine versus tolterodine in older and younger subjects with overactive bladder: a post hoc, pooled analysis from two placebo-controlled trials. Neurourol Urodyn, 2012. 31: 1258.

https://www.ncbi.nlm.nih.gov/pubmed/22907761

172.Shamliyan, T.A., et al. Systematic review: randomized, controlled trials of nonsurgical treatments for urinary incontinence in women. Ann Intern Med, 2008. 148: 459.

https://www.ncbi.nlm.nih.gov/pubmed/18268288

173.Hartmann, K.E., et al. Treatment of overactive bladder in women. Evid Rep Technol Assess (Full Rep), 2009: 1.

https://www.ncbi.nlm.nih.gov/pubmed/19947666

174.Goode, P.S., et al. Incontinence in older women. JAMA, 2010. 303: 2172.

https://www.ncbi.nlm.nih.gov/pubmed/20516418

175.Gormley, E.A., et al. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. J Urol, 2012. 188: 2455.

https://www.ncbi.nlm.nih.gov/pubmed/23098785

176.Mattiasson, A., et al. Efficacy of simplified bladder training in patients with overactive bladder receiving a solifenacin flexible-dose regimen: results from a randomized study. BJU Int, 2010. 105: 1126.

https://www.ncbi.nlm.nih.gov/pubmed/19818077

177.Ayeleke, R.O., et al. Pelvic floor muscle training added to another active treatment versus the same active treatment alone for urinary incontinence in women. Cochrane Database Syst Rev, 2015. 2015: CD010551.

https://www.ncbi.nlm.nih.gov/pubmed/26526663

178.Kosilov, K.V., et al. Randomized controlled trial of cyclic and continuous therapy with trospium and solifenacin combination for severe overactive bladder in elderly patients with regard to patient compliance. Ther Adv Urol, 2014. 6: 215.

https://www.ncbi.nlm.nih.gov/pubmed/25435915

179.Sand, P.K., et al. Long-term safety, tolerability and efficacy of fesoterodine in subjects with overactive bladder symptoms stratified by age: pooled analysis of two open-label extension studies. Drugs Aging, 2012. 29: 119.

https://www.ncbi.nlm.nih.gov/pubmed/22276958

180.Scarpero, H., et al. Long-term safety, tolerability, and efficacy of fesoterodine treatment in men and women with overactive bladder symptoms. Curr Med Res Opin, 2011. 27: 921.

https://www.ncbi.nlm.nih.gov/pubmed/21355814

181.Kalder, M., et al. Discontinuation of treatment using anticholinergic medications in patients with urinary incontinence. Obstet Gynecol, 2014. 124: 794.

https://www.ncbi.nlm.nih.gov/pubmed/25198276

182.Sears, C.L., et al. Overactive bladder medication adherence when medication is free to patients. J Urol, 2010. 183: 1077.

https://www.ncbi.nlm.nih.gov/pubmed/20092838

183.Cui, Y., et al. The efficacy and safety of mirabegron in treating OAB: a systematic review and meta-analysis of phase III trials. Int Urol Nephrol, 2014. 46: 275.

https://www.ncbi.nlm.nih.gov/pubmed/23896942

184.Chapple, C.R., et al. Mirabegron in overactive bladder: a review of efficacy, safety, and tolerability. Neurourol Urodyn, 2014. 33: 17.

https://www.ncbi.nlm.nih.gov/pubmed/24127366

185.Yamaguchi, O., et al. Phase III, randomised, double-blind, placebo-controlled study of the beta3-adrenoceptor agonist mirabegron, 50 mg once daily, in Japanese patients with overactive bladder. BJU Int, 2014. 113: 951.

https://www.ncbi.nlm.nih.gov/pubmed/24471907

186.Chapple, C.R., et al. Randomized double-blind, active-controlled phase 3 study to assess 12-month safety and efficacy of mirabegron, a beta(3)-adrenoceptor agonist, in overactive bladder. Eur Urol, 2013. 63: 296.

https://www.ncbi.nlm.nih.gov/pubmed/23195283

187.Su, S., et al. Systematic review and meta-analysis of the efficacy and safety of vibegron vs antimuscarinic monotherapy for overactive bladder. Medicine (Baltimore), 2021. 100: e23171.

https://www.ncbi.nlm.nih.gov/pubmed/33592817

188.Athanasiou, S., et al. Mirabegron in female patients with overactive bladder syndrome: What's new? A systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol, 2020. 251: 73.

https://www.ncbi.nlm.nih.gov/pubmed/32480182

189.Malik, M., et al. Proarrhythmic safety of repeat doses of mirabegron in healthy subjects: a randomized, double-blind, placebo-, and active-controlled thorough QT study. Clin Pharmacol Ther, 2012. 92: 696.

https://www.ncbi.nlm.nih.gov/pubmed/23149929

190.Martin, N., et al. Randomised, double-blind, placebo-controlled study to assess the ocular safety of mirabegron in normotensive IOP research subjects. Eur Urol Suppl, 2014. 13: e686.

https://doi.org/10.1016/S1569-9056(12)60683-6

191.MacDiarmid, S., et al. Mirabegron as Add-On Treatment to Solifenacin in Patients with Incontinent Overactive Bladder and an Inadequate Response to Solifenacin Monotherapy: Responder Analyses and Patient-Reported Outcomes from the BESIDE Study [corrected]. J Urol, 2016. 196: 809.

https://www.ncbi.nlm.nih.gov/pubmed/27063854

192.He, W., et al. Efficacy and safety of vibegron compared with mirabegron for overactive bladder: A systematic review and network meta-analysis. Low Urin Tract Symptoms, 2023. 15: 80.

https://www.ncbi.nlm.nih.gov/pubmed/36863312

193.Kennelly, M., et al. Long-term efficacy and safety of vibegron versus mirabegron and anticholinergics for overactive bladder: a systematic review and network meta-analysis. Drugs Context, 2022. 11.

https://www.ncbi.nlm.nih.gov/pubmed/36303599

194.Wagg, A., et al. Persistence and adherence with the new beta-3 receptor agonist, mirabegron, versus antimuscarinics in overactive bladder: Early experience in Canada. Can Urol Assoc J, 2015. 9: 343.

https://www.ncbi.nlm.nih.gov/pubmed/26644809

195.Tannenbaum, C., et al. A systematic review of amnestic and non-amnestic mild cognitive impairment induced by anticholinergic, antihistamine, GABAergic and opioid drugs. Drugs Aging, 2012. 29: 639.

https://www.ncbi.nlm.nih.gov/pubmed/22812538

196.Gray, S.L., et al. Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. JAMA Intern Med, 2015. 175: 401.

https://www.ncbi.nlm.nih.gov/pubmed/25621434

197.Risacher, S.L., et al. Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older Adults. JAMA Neurol, 2016. 73: 721.

https://www.ncbi.nlm.nih.gov/pubmed/27088965

198.Kessler, T.M., et al. Adverse event assessment of antimuscarinics for treating overactive bladder: a network meta-analytic approach. PLoS One, 2011. 6: e16718.

https://www.ncbi.nlm.nih.gov/pubmed/21373193

199.Paquette, A., et al. Systematic review and meta-analysis: do clinical trials testing antimuscarinic agents for overactive bladder adequately measure central nervous system adverse events? J Am Geriatr Soc, 2011. 59: 1332.

https://www.ncbi.nlm.nih.gov/pubmed/21718264

200.Kay, G., et al. Differential effects of the antimuscarinic agents darifenacin and oxybutynin ER on memory in older subjects. Eur Urol, 2006. 50: 317.

https://www.ncbi.nlm.nih.gov/pubmed/16687205

201.Isik, A.T., et al. Trospium and cognition in patients with late onset Alzheimer disease. J Nutr Health Aging, 2009. 13: 672.

https://www.ncbi.nlm.nih.gov/pubmed/19657549

202.Lackner, T.E., et al. Randomized, placebo-controlled trial of the cognitive effect, safety, and tolerability of oral extended-release oxybutynin in cognitively impaired nursing home residents with urge urinary incontinence. J Am Geriatr Soc, 2008. 56: 862.

https://www.ncbi.nlm.nih.gov/pubmed/18410326

203.Wagg, A., et al. Randomised, multicentre, placebo-controlled, double-blind crossover study investigating the effect of solifenacin and oxybutynin in elderly people with mild cognitive impairment: the SENIOR study. Eur Urol, 2013. 64: 74.

https://www.ncbi.nlm.nih.gov/pubmed/23332882

204.Sink, K.M., et al. Dual use of bladder anticholinergics and cholinesterase inhibitors: long-term functional and cognitive outcomes. J Am Geriatr Soc, 2008. 56: 847.

https://www.ncbi.nlm.nih.gov/pubmed/18384584

205.Wagg, A., et al. Efficacy and tolerability of solifenacin in elderly subjects with overactive bladder syndrome: a pooled analysis. Am J Geriatr Pharmacother, 2006. 4: 14.

https://www.ncbi.nlm.nih.gov/pubmed/16730617

206.Wesnes, K.A., et al. Exploratory pilot study assessing the risk of cognitive impairment or sedation in the elderly following single doses of solifenacin 10 mg. Expert Opin Drug Saf, 2009. 8: 615.

https://www.ncbi.nlm.nih.gov/pubmed/19747069

207.Zinner, N., et al. Impact of solifenacin on quality of life, medical care use, work productivity, and health utility in the elderly: an exploratory subgroup analysis. Am J Geriatr Pharmacother, 2009. 7: 373.

https://www.ncbi.nlm.nih.gov/pubmed/20129258

208.Herschorn, S., et al. Tolerability of solifenacin and oxybutynin immediate release in older (> 65 years) and younger (</= 65 years) patients with overactive bladder: sub-analysis from a Canadian, randomized, double-blind study. Curr Med Res Opin, 2011. 27: 375.

https://www.ncbi.nlm.nih.gov/pubmed/21175373

209.Drutz, H.P., et al. Clinical efficacy and safety of tolterodine compared to oxybutynin and placebo in patients with overactive bladder. Int Urogynecol J Pelvic Floor Dysfunct, 1999. 10: 283.

https://www.ncbi.nlm.nih.gov/pubmed/10543335

210.Michel, M.C., et al. Does gender or age affect the efficacy and safety of tolterodine? J Urol, 2002. 168: 1027.

https://www.ncbi.nlm.nih.gov/pubmed/12187215

211.Millard, R., et al. Clinical efficacy and safety of tolterodine compared to placebo in detrusor overactivity. J Urol, 1999. 161: 1551.

https://www.ncbi.nlm.nih.gov/pubmed/10210394

212.Zinner, N.R., et al. Efficacy, safety, and tolerability of extended-release once-daily tolterodine treatment for overactive bladder in older versus younger patients. J Am Geriatr Soc, 2002. 50: 799.

https://www.ncbi.nlm.nih.gov/pubmed/12028164

213.Jumadilova, Z., et al. Retrospective evaluation of outcomes in patients with overactive bladder receiving tolterodine versus oxybutynin. Am J Health Syst Pharm, 2006. 63: 2357.

https://www.ncbi.nlm.nih.gov/pubmed/17106009

214.Chapple, C., et al. Darifenacin treatment of patients >or= 65 years with overactive bladder: results of a randomized, controlled, 12-week trial. Curr Med Res Opin, 2007. 23: 2347.

https://www.ncbi.nlm.nih.gov/pubmed/17706004

215.Lipton, R.B., et al. Assessment of cognitive function of the elderly population: effects of darifenacin. J Urol, 2005. 173: 493.

https://www.ncbi.nlm.nih.gov/pubmed/15643227

216.Pietzko, A., et al. Influences of trospium chloride and oxybutynin on quantitative EEG in healthy volunteers. Eur J Clin Pharmacol, 1994. 47: 337.

https://www.ncbi.nlm.nih.gov/pubmed/7875185

217.Todorova, A., et al. Effects of tolterodine, trospium chloride, and oxybutynin on the central nervous system. J Clin Pharmacol, 2001. 41: 636.

https://www.ncbi.nlm.nih.gov/pubmed/11402632

218.Staskin, D.R., et al. Trospium chloride once-daily extended release is effective and well tolerated for the treatment of overactive bladder syndrome: an integrated analysis of two randomised, phase III trials. Int J Clin Pract, 2009. 63: 1715.

https://www.ncbi.nlm.nih.gov/pubmed/19930332

219.Sand, P.K., et al. Trospium chloride once-daily extended release is efficacious and tolerated in elderly subjects (aged >/= 75 years) with overactive bladder syndrome. BJU Int, 2011. 107: 612.

https://www.ncbi.nlm.nih.gov/pubmed/20707790

220.Kraus, S.R., et al. Efficacy and tolerability of fesoterodine in older and younger subjects with overactive bladder. Urology, 2010. 76: 1350.

https://www.ncbi.nlm.nih.gov/pubmed/20974482

221.Dubeau, C.E., et al. Effect of fesoterodine in vulnerable elderly subjects with urgency incontinence: a double-blind, placebo controlled trial. J Urol, 2014. 191: 395.

https://www.ncbi.nlm.nih.gov/pubmed/23973522

222.Wagg, A., et al. Review of the efficacy and safety of fesoterodine for treating overactive bladder and urgency urinary incontinence in elderly patients. Drugs Aging, 2015. 32: 103.

https://www.ncbi.nlm.nih.gov/pubmed/25673122

223.Ancelin, M.L., et al. Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. BMJ, 2006. 332: 455.

https://www.ncbi.nlm.nih.gov/pubmed/16452102

224.Wagg, A., et al. Review of cognitive impairment with antimuscarinic agents in elderly patients with overactive bladder. Int J Clin Pract, 2010. 64: 1279.

https://www.ncbi.nlm.nih.gov/pubmed/20529135

225.Wagg, A., et al. Long-term safety, tolerability and efficacy of flexible-dose fesoterodine in elderly patients with overactive bladder: open-label extension of the SOFIA trial. Neurourol Urodyn, 2014. 33: 106.

https://www.ncbi.nlm.nih.gov/pubmed/23460503

226.Boustani, M., et al. Impact of anticholinergics on the aging brain: a review and practical application. Aging Health, 2008. 4: 311.

https://doi.org/10.2217/1745509X.4.3.311

227.Cai, X., et al. Long-term anticholinergic use and the aging brain. Alzheimers Dement, 2013. 9: 377.

https://www.ncbi.nlm.nih.gov/pubmed/23183138

228.Campbell, N., et al. The cognitive impact of anticholinergics: a clinical review. Clin Interv Aging, 2009. 4: 225.

https://www.ncbi.nlm.nih.gov/pubmed/19554093

229.Carriere, I., et al. Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study. Arch Intern Med, 2009. 169: 1317.

https://www.ncbi.nlm.nih.gov/pubmed/19636034

230.Fox, C., et al. Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study. J Am Geriatr Soc, 2011. 59: 1477.

https://www.ncbi.nlm.nih.gov/pubmed/21707557

231.Rogers, R.G., et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for the assessment of sexual health of women with pelvic floor dysfunction. Neurourol Urodyn, 2018. 37: 1220.

https://www.ncbi.nlm.nih.gov/pubmed/29441607

232.Biehl, C., et al. A systematic review of the efficacy and safety of vaginal estrogen products for the treatment of genitourinary syndrome of menopause. Menopause, 2019. 26: 431.

https://www.ncbi.nlm.nih.gov/pubmed/30363010

233.Cody, J.D., et al. Oestrogen therapy for urinary incontinence in post-menopausal women. Cochrane Database Syst Rev, 2012. 10: CD001405.

https://www.ncbi.nlm.nih.gov/pubmed/23076892

234.Lyytinen, H., et al. Breast cancer risk in postmenopausal women using estrogen-only therapy. Obstet Gynecol, 2006. 108: 1354.

https://www.ncbi.nlm.nih.gov/pubmed/17138766

235.Yumru, A.E., et al. The use of local 17beta-oestradiol treatment for improving vaginal symptoms associated with post-menopausal oestrogen deficiency. J Int Med Res, 2009. 37: 198.

https://www.ncbi.nlm.nih.gov/pubmed/19215691

236.Mostafaei, H., et al. Nocebo Response in the Pharmacological Management of Overactive Bladder: A Systematic Review and Meta-analysis. Eur Urol Focus, 2021. 7: 1143.

https://www.ncbi.nlm.nih.gov/pubmed/33153953

237.Yamada, S., et al. Beneficial Effects of Saw Palmetto Fruit Extract on Urinary Symptoms in Japanese Female Subjects by a Multicenter, Randomized, Double-Blind, Placebo-Controlled Study. Nutrients, 2022. 14: 1190.

https://www.ncbi.nlm.nih.gov/pubmed/35334848

238.Mangera, A., et al. Contemporary management of lower urinary tract disease with botulinum toxin A: a systematic review of botox (onabotulinumtoxinA) and dysport (abobotulinumtoxinA). Eur Urol, 2011. 60: 784.

https://www.ncbi.nlm.nih.gov/pubmed/21782318

239.Chapple, C., et al. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial. Eur Urol, 2013. 64: 249.

https://www.ncbi.nlm.nih.gov/pubmed/23608668

240.Veeratterapillay, R., et al. Discontinuation rates and inter-injection interval for repeated intravesical botulinum toxin type A injections for detrusor overactivity. Int J Urol, 2014. 21: 175.

https://www.ncbi.nlm.nih.gov/pubmed/23819724

241.Mohee, A., et al. Long-term outcome of the use of intravesical botulinum toxin for the treatment of overactive bladder (OAB). BJU Int, 2013. 111: 106.

https://www.ncbi.nlm.nih.gov/pubmed/22672569

242.Nitti, V.W., et al. OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial. J Urol, 2013. 189: 2186.

https://www.ncbi.nlm.nih.gov/pubmed/23246476

243.Duthie, J.B., et al. Botulinum toxin injections for adults with overactive bladder syndrome. Cochrane Database Syst Rev, 2011: CD005493.

https://www.ncbi.nlm.nih.gov/pubmed/22161392

244.White, W.M., et al. Short-term efficacy of botulinum toxin a for refractory overactive bladder in the elderly population. J Urol, 2008. 180: 2522.

https://www.ncbi.nlm.nih.gov/pubmed/18930481

245.Nitti, V.W., et al. Durable Efficacy and Safety of Long-Term OnabotulinumtoxinA Treatment in Patients with Overactive Bladder Syndrome: Final Results of a 3.5-Year Study. J Urol, 2016. 196: 791.

https://www.ncbi.nlm.nih.gov/pubmed/27038769

246.Alshammari, D., et al. Intradetrusor Versus Suburothelial Onabotulinum Toxin A in Adults with Neurogenic and Non-neurogenic Overactive Bladder Syndrome: A Meta-Analysis. Arch Esp Urol, 2024. 77: 368.

https://www.ncbi.nlm.nih.gov/pubmed/38840279

247.Rovner, E., et al. Urodynamic results and clinical outcomes with intradetrusor injections of onabotulinumtoxinA in a randomized, placebo-controlled dose-finding study in idiopathic overactive bladder. Neurourol Urodyn, 2011. 30: 556.

https://www.ncbi.nlm.nih.gov/pubmed/21351127

248.Jairam, R., et al. Predictive Factors in Sacral Neuromodulation: A Systematic Review. Urol Int, 2022. 106: 323.

https://www.ncbi.nlm.nih.gov/pubmed/34058731

249.Amundsen, C.L., et al. Two-Year Outcomes of Sacral Neuromodulation Versus OnabotulinumtoxinA for Refractory Urgency Urinary Incontinence: A Randomized Trial. Eur Urol, 2018. 74: 66.

https://www.ncbi.nlm.nih.gov/pubmed/29482936

250.Siegel, S., et al. Results of a prospective, randomized, multicenter study evaluating sacral neuromodulation with InterStim therapy compared to standard medical therapy at 6-months in subjects with mild symptoms of overactive bladder. Neurourol Urodyn, 2015. 34: 224.

https://www.ncbi.nlm.nih.gov/pubmed/24415559

251.Herbison, G.P., et al. Sacral neuromodulation with implanted devices for urinary storage and voiding dysfunction in adults. Cochrane Database Syst Rev, 2009: CD004202.

https://www.ncbi.nlm.nih.gov/pubmed/19370596

252.Weil, E.H., et al. Sacral root neuromodulation in the treatment of refractory urinary urge incontinence: a prospective randomized clinical trial. Eur Urol, 2000. 37: 161.

https://www.ncbi.nlm.nih.gov/pubmed/10705194

253.Schmidt, R.A., et al. Sacral nerve stimulation for treatment of refractory urinary urge incontinence. Sacral Nerve Stimulation Study Group. J Urol, 1999. 162: 352.

https://www.ncbi.nlm.nih.gov/pubmed/10411037

254.Chartier-Kastler, E., et al. Sacral Neuromodulation with the InterStim System for Overactive Bladder: 3-Year Results from the French Prospective, Multicenter, Observational SOUNDS Study. Eur Urol Focus, 2022. 8: 1399.

https://www.ncbi.nlm.nih.gov/pubmed/34334342

255.Chartier-Kastler, E., et al. Five-year Results from the Prospective, Multicenter, Observational SOUNDS Study of Patients with Overactive Bladder Treated with the InterStim System for Sacral Neuromodulation. Eur Urol Focus, 2023. 9: 765.

https://www.ncbi.nlm.nih.gov/pubmed/37019729

256.Tutolo, M., et al. Efficacy and Safety of Sacral and Percutaneous Tibial Neuromodulation in Non-neurogenic Lower Urinary Tract Dysfunction and Chronic Pelvic Pain: A Systematic Review of the Literature. Eur Urol, 2018. 73: 406.

https://www.ncbi.nlm.nih.gov/pubmed/29336927

257.van Kerrebroeck, P.E., et al. Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. J Urol, 2007. 178: 2029.

https://www.ncbi.nlm.nih.gov/pubmed/17869298

258.Amundsen, C.L., et al. OnabotulinumtoxinA vs Sacral Neuromodulation on Refractory Urgency Urinary Incontinence in Women: A Randomized Clinical Trial. JAMA, 2016. 316: 1366.

https://www.ncbi.nlm.nih.gov/pubmed/27701661

259.Groenendijk, P.M., et al. Urodynamic evaluation of sacral neuromodulation for urge urinary incontinence. BJU Int, 2008. 101: 325.

https://www.ncbi.nlm.nih.gov/pubmed/18070199

260.Alsulihem, A., et al. The use of vaginal lasers in the treatment of urinary incontinence and overactive bladder, systematic review. Int Urogynecol J, 2021. 32: 553.

https://www.ncbi.nlm.nih.gov/pubmed/33175226

261.Cody, J.D., et al. Urinary diversion and bladder reconstruction/replacement using intestinal segments for intractable incontinence or following cystectomy. Cochrane Database Syst Rev, 2012. 2012: CD003306.

https://www.ncbi.nlm.nih.gov/pubmed/22336788

262.Kockelbergh, R.C., et al. Clam enterocystoplasty in general urological practice. Br J Urol, 1991. 68: 38.

https://www.ncbi.nlm.nih.gov/pubmed/1873689

263.Cohen, A.J., et al. Comparative Outcomes and Perioperative Complications of Robotic Vs Open Cystoplasty and Complex Reconstructions. Urology, 2016. 97: 172.

https://www.ncbi.nlm.nih.gov/pubmed/27443464

264.Awad, S.A., et al. Long-term results and complications of augmentation ileocystoplasty for idiopathic urge incontinence in women. Br J Urol, 1998. 81: 569.

https://www.ncbi.nlm.nih.gov/pubmed/9598629

265.Lane, T., et al. Carcinoma following augmentation ileocystoplasty. Urol Int, 2000. 64: 31.

https://www.ncbi.nlm.nih.gov/pubmed/10782030

266.Stone, A.R., et al. Carcinoma associated with augmentation cystoplasty. Br J Urol, 1987. 60: 236.

https://www.ncbi.nlm.nih.gov/pubmed/3676669

267.Leedham, P.W., et al. Adenocarcinoma developing in an ileocystoplasty. Br J Surg, 1973. 60: 158.

https://www.ncbi.nlm.nih.gov/pubmed/4685940

268.Biardeau, X., et al. Risk of malignancy after augmentation cystoplasty: A systematic review. Neurourol Urodyn, 2016. 35: 675.

https://www.ncbi.nlm.nih.gov/pubmed/25867054

269.Greenwell, T.J., et al. Augmentation cystoplasty. BJU Int, 2001. 88: 511.

https://www.ncbi.nlm.nih.gov/pubmed/11678743

270.Covert, W.M., et al. The role of mucoregulatory agents after continence-preserving urinary diversion surgery. Am J Health Syst Pharm, 2012. 69: 483.

https://www.ncbi.nlm.nih.gov/pubmed/22382478

271.Padmanabhan, P., et al. Five-year cost analysis of intra-detrusor injection of botulinum toxin type A and augmentation cystoplasty for refractory neurogenic detrusor overactivity. World J Urol, 2011. 29: 51.

https://www.ncbi.nlm.nih.gov/pubmed/21110030

272.Cartwright, P.C., et al. Bladder autoaugmentation: partial detrusor excision to augment the bladder without use of bowel. J Urol, 1989. 142: 1050.

https://www.ncbi.nlm.nih.gov/pubmed/2795729

273.Leng, W.W., et al. Enterocystoplasty or detrusor myectomy? Comparison of indications and outcomes for bladder augmentation. J Urol, 1999. 161: 758.

https://www.ncbi.nlm.nih.gov/pubmed/10022679

274.ter Meulen, P.H., et al. A study on the feasibility of vesicomyotomy in patients with motor urge incontinence. Eur Urol, 1997. 32: 166.

https://www.ncbi.nlm.nih.gov/pubmed/9286647

275.Wu, J.M., et al. Forecasting the prevalence of pelvic floor disorders in U.S. Women: 2010 to 2050. Obstet Gynecol, 2009. 114: 1278.

https://www.ncbi.nlm.nih.gov/pubmed/19935030

276.Hunskaar, S., et al. The prevalence of urinary incontinence in women in four European countries. BJU Int, 2004. 93: 324.

https://www.ncbi.nlm.nih.gov/pubmed/14764130

277.Thom, D.H., et al. Differences in prevalence of urinary incontinence by race/ethnicity. J Urol, 2006. 175: 259.

https://www.ncbi.nlm.nih.gov/pubmed/16406923

278.Mitchell, E.S., et al. Correlates of urinary incontinence during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study. Climacteric, 2013. 16: 653.

https://www.ncbi.nlm.nih.gov/pubmed/23560943

279.Chen, X., et al. Association between obesity and urinary incontinence in older adults from multiple nationwide longitudinal cohorts. Commun Med (Lond), 2023. 3: 142.

https://www.ncbi.nlm.nih.gov/pubmed/37821658

280.Minassian, V.A., et al. Urinary incontinence in women: variation in prevalence estimates and risk factors. Obstet Gynecol, 2008. 111: 324.

https://www.ncbi.nlm.nih.gov/pubmed/18238969

281.Brown, J.S., et al. Urinary incontinence in older women: who is at risk? Study of Osteoporotic Fractures Research Group. Obstet Gynecol, 1996. 87: 715.

https://www.ncbi.nlm.nih.gov/pubmed/8677073

282.Bo, K., et al. Is Physical Activity Good or Bad for the Female Pelvic Floor? A Narrative Review. Sports Med, 2020. 50: 471.

https://www.ncbi.nlm.nih.gov/pubmed/31820378

283.Huang, H., et al. Associations between metabolic syndrome and female stress urinary incontinence: a meta-analysis. Int Urogynecol J, 2022. 33: 2073.

https://www.ncbi.nlm.nih.gov/pubmed/35122481

284.DeLancey, J.O. Structural support of the urethra as it relates to stress urinary incontinence: the hammock hypothesis. Am J Obstet Gynecol, 1994. 170: 1713.

https://www.ncbi.nlm.nih.gov/pubmed/8203431

285.Aoki, Y., et al. Urinary incontinence in women. Nat Rev Dis Primers, 2017. 3: 17042.

https://www.ncbi.nlm.nih.gov/pubmed/28681849

286.Hillary, C.J., et al. Considerations in the modern management of stress urinary incontinence resulting from intrinsic sphincter deficiency. World J Urol, 2015. 33: 1251.

https://www.ncbi.nlm.nih.gov/pubmed/26060138

287.Medina, C.A., et al. Evaluation and surgery for stress urinary incontinence: A FIGO working group report. Neurourol Urodyn, 2017. 36: 518.

https://www.ncbi.nlm.nih.gov/pubmed/26950893

288.Patnam, R., et al. Standing Vs Supine; Does it Matter in Cough Stress Testing? Female Pelvic Med Reconstr Surg, 2017. 23: 315.

https://www.ncbi.nlm.nih.gov/pubmed/28079569

289.Guralnick, M.L., et al. ICS Educational Module: Cough stress test in the evaluation of female urinary incontinence: Introducing the ICS-Uniform Cough Stress Test. Neurourol Urodyn, 2018. 37: 1849.

https://www.ncbi.nlm.nih.gov/pubmed/29926966

290.Loganathan, J., et al. Which patient reported outcomes (PROs) and patient reported outcome measures (PROMs) do researchers select in stress urinary incontinence surgical trials? - a systematic review. Int Urogynecol J, 2022. 33: 2941.

https://www.ncbi.nlm.nih.gov/pubmed/35254471

291.Zehnder, P., et al. Air charged and microtip catheters cannot be used interchangeably for urethral pressure measurement: a prospective, single-blind, randomized trial. J Urol, 2008. 180: 1013.

https://www.ncbi.nlm.nih.gov/pubmed/18639301

292.Sirls, L.T., et al. The effect of urodynamic testing on clinical diagnosis, treatment plan and outcomes in women undergoing stress urinary incontinence surgery. J Urol, 2013. 189: 204.

https://www.ncbi.nlm.nih.gov/pubmed/22982425

293.van Leijsen, S.A., et al. Can preoperative urodynamic investigation be omitted in women with stress urinary incontinence? A non-inferiority randomized controlled trial. Neurourol Urodyn, 2012. 31: 1118.

https://www.ncbi.nlm.nih.gov/pubmed/22488817

294.van Leijsen, S.A.L., et al. Value of urodynamics before stress urinary incontinence surgery: a randomized controlled trial. Obstet Gynecol, 2013. 121: 999.

https://www.ncbi.nlm.nih.gov/pubmed/23635736

295.Costantini, E., et al. Preoperative Valsalva leak point pressure may not predict outcome of mid-urethral slings. Analysis from a randomized controlled trial of retropubic versus transobturator mid-urethral slings. Int Braz J Urol, 2008. 34: 73.

https://www.ncbi.nlm.nih.gov/pubmed/18341724

296.Finazzi-Agro, E., et al. Comments on "A randomized trial of urodynamic testing before stress-incontinence surgery" (N Engl J Med. 2012 May 24;366(21):1987-1997) From the Italian Society of Urodynamics. Neurourol Urodyn, 2013. 32: 301.

https://www.ncbi.nlm.nih.gov/pubmed/23023985

297.Lewicky-Gaupp, C., et al. "The cough game": are there characteristic urethrovesical movement patterns associated with stress incontinence? Int Urogynecol J Pelvic Floor Dysfunct, 2009. 20: 171.

https://www.ncbi.nlm.nih.gov/pubmed/18850057

298.Shek, K.L., et al. The effect of childbirth on urethral mobility: a prospective observational study. J Urol, 2010. 184: 629.

https://www.ncbi.nlm.nih.gov/pubmed/20639028

299.Kociszewski, J., et al. Tape functionality: sonographic tape characteristics and outcome after TVT incontinence surgery. Neurourol Urodyn, 2008. 27: 485.

https://www.ncbi.nlm.nih.gov/pubmed/18288705

300.Bo, K. Mechanisms for pelvic floor muscle training: Morphological changes and associations between changes in pelvic floor muscle variables and symptoms of female stress urinary incontinence and pelvic organ prolapse-A narrative review. Neurourol Urodyn, 2024. 43: 1977.

https://www.ncbi.nlm.nih.gov/pubmed/38979823

301.Morgan, D.M., et al. Urethral sphincter morphology and function with and without stress incontinence. J Urol, 2009. 182: 203.

https://www.ncbi.nlm.nih.gov/pubmed/19450822

302.Nguyen, L., et al. Surgical technique to overcome anatomical shortcoming: balancing post-prostatectomy continence outcomes of urethral sphincter lengths on preoperative magnetic resonance imaging. J Urol, 2008. 179: 1907.

https://www.ncbi.nlm.nih.gov/pubmed/18353395

303.Nygaard, I., et al. Prevalence of symptomatic pelvic floor disorders in US women. JAMA, 2008. 300: 1311.

https://www.ncbi.nlm.nih.gov/pubmed/18799443

304.de Mattos Lourenco, T.R., et al. Urinary incontinence in female athletes: a systematic review. Int Urogynecol J, 2018. 29: 1757.

https://www.ncbi.nlm.nih.gov/pubmed/29552736

305.Gozukara, Y.M., et al. The improvement in pelvic floor symptoms with weight loss in obese women does not correlate with the changes in pelvic anatomy. Int Urogynecol J, 2014. 25: 1219.

https://www.ncbi.nlm.nih.gov/pubmed/24711149

306.Brown, J.S., et al. Lifestyle intervention is associated with lower prevalence of urinary incontinence: the Diabetes Prevention Program. Diabetes Care, 2006. 29: 385.

https://www.ncbi.nlm.nih.gov/pubmed/16443892

307.Bump, R.C., et al. Obesity and lower urinary tract function in women: effect of surgically induced weight loss. Am J Obstet Gynecol, 1992. 167: 392.

https://www.ncbi.nlm.nih.gov/pubmed/1497041

308.Subak, L.L., et al. Does weight loss improve incontinence in moderately obese women? Int Urogynecol J Pelvic Floor Dysfunct, 2002. 13: 40.

https://www.ncbi.nlm.nih.gov/pubmed/11999205

309.Wing, R.R., et al. Improving urinary incontinence in overweight and obese women through modest weight loss. Obstet Gynecol, 2010. 116: 284.

https://www.ncbi.nlm.nih.gov/pubmed/20664387

310.Subak, L.L., et al. Weight loss: a novel and effective treatment for urinary incontinence. J Urol, 2005. 174: 190.

https://www.ncbi.nlm.nih.gov/pubmed/15947625

311.Leshem, A., et al. Effects of Bariatric Surgery on Female Pelvic Floor Disorders. Urology, 2017. 105: 42.

https://www.ncbi.nlm.nih.gov/pubmed/28315786

312.Knepfler, T., et al. Bariatric surgery improves female pelvic floor disorders. J Visc Surg, 2016. 153: 95.

https://www.ncbi.nlm.nih.gov/pubmed/26678846

313.Subak, L.L., et al. Urinary Incontinence Before and After Bariatric Surgery. JAMA Intern Med, 2015. 175: 1378.

https://www.ncbi.nlm.nih.gov/pubmed/26098620

314.Miller, J.M., et al. A pelvic muscle precontraction can reduce cough-related urine loss in selected women with mild SUI. J Am Geriatr Soc, 1998. 46: 870.

https://www.ncbi.nlm.nih.gov/pubmed/9670874

315.Bo, K. Pelvic floor muscle training is effective in treatment of female stress urinary incontinence, but how does it work? Int Urogynecol J Pelvic Floor Dysfunct, 2004. 15: 76.

https://www.ncbi.nlm.nih.gov/pubmed/15014933

316.Zubieta, M., et al. Influence of voluntary pelvic floor muscle contraction and pelvic floor muscle training on urethral closure pressures: a systematic literature review. Int Urogynecol J, 2016. 27: 687.

https://www.ncbi.nlm.nih.gov/pubmed/26407561

317.Braekken, I.H., et al. Can pelvic floor muscle training reverse pelvic organ prolapse and reduce prolapse symptoms? An assessor-blinded, randomized, controlled trial. Am J Obstet Gynecol, 2010. 203: 170 e1.

https://www.ncbi.nlm.nih.gov/pubmed/20435294

318.Hao, J., et al. Pelvic floor muscle training in telerehabilitation: a systematic review and meta-analysis. Arch Gynecol Obstet, 2024. 309: 1753.

https://www.ncbi.nlm.nih.gov/pubmed/38340157

319.Dumoulin, C., et al. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database Syst Rev, 2018. 10: CD005654.

https://www.ncbi.nlm.nih.gov/pubmed/30288727

320.Hagen, S., Elders, A, Henderson L, Kilonzo, M, McClurg, D, Hay-Smith, J, Dean, S, Booth, J, et al. , Effectiveness and cost-effectiveness of biofeedback-assisted pelvic floor muscle training for female urinary incontinence: a multicentre randomised controlled trial (abstract 485), in ICS2019. 2019, ICS: Gothenburg, Sweden.

321.Dumoulin, C., et al. Group-Based vs Individual Pelvic Floor Muscle Training to Treat Urinary Incontinence in Older Women: A Randomized Clinical Trial. JAMA Intern Med, 2020. 180: 1284.

https://www.ncbi.nlm.nih.gov/pubmed/32744599

322.Hay-Smith, E.J., et al. Comparisons of approaches to pelvic floor muscle training for urinary incontinence in women. Cochrane Database Syst Rev, 2011: CD009508.

https://www.ncbi.nlm.nih.gov/pubmed/22161451

323.Herbison, G.P., et al. Weighted vaginal cones for urinary incontinence. Cochrane Database Syst Rev, 2013. 2013: CD002114.

https://www.ncbi.nlm.nih.gov/pubmed/23836411

324.Dumoulin, C., et al., Conservative management, in Incontinence, C. Abrams P, Wagg A, Wein A, eds. , Editor. 2017.

https://www.ics.org/Publications/ICI_5/INCONTINENCE.pdf

325.Labrie, J., et al. Surgery versus physiotherapy for stress urinary incontinence. N Engl J Med, 2013. 369: 1124.

https://www.ncbi.nlm.nih.gov/pubmed/24047061

326.Bo, K., et al. Does it work in the long term?--A systematic review on pelvic floor muscle training for female stress urinary incontinence. Neurourol Urodyn, 2013. 32: 215.

https://www.ncbi.nlm.nih.gov/pubmed/22847318

327.Woodley, S.J., et al. Pelvic floor muscle training for preventing and treating urinary and faecal incontinence in antenatal and postnatal women. Cochrane Database Syst Rev, 2020. 5: CD007471.

https://www.ncbi.nlm.nih.gov/pubmed/32378735

328.Sigurdardottir, T., et al. Can postpartum pelvic floor muscle training reduce urinary and anal incontinence?: An assessor-blinded randomized controlled trial. Am J Obstet Gynecol, 2020. 222: 247 e1.

https://www.ncbi.nlm.nih.gov/pubmed/31526791

329.Wagg, A., Chen, LK, Johnson, T, et al. Committee 11, Incontinence in frail older persons, in Incontinence, P. Abrams, et al., Editor. 2017.

https://www.ics.org/Publications/ICI_5/INCONTINENCE.pdf

330.Stenzelius, K., et al. The effect of conservative treatment of urinary incontinence among older and frail older people: a systematic review. Age Ageing, 2015. 44: 736.

https://www.ncbi.nlm.nih.gov/pubmed/26112402

331.Mateus-Vasconcelos, E.C.L., et al. Effects of three interventions in facilitating voluntary pelvic floor muscle contraction in women: a randomized controlled trial. Braz J Phys Ther, 2018. 22: 391.

https://www.ncbi.nlm.nih.gov/pubmed/29429823

332.Ignacio Antonio, F., et al. Intravaginal electrical stimulation increases voluntarily pelvic floor muscle contractions in women who are unable to voluntarily contract their pelvic floor muscles: a randomised trial. J Physiother, 2022. 68: 37.

https://www.ncbi.nlm.nih.gov/pubmed/34952812

333.McLean, L., et al. Pelvic floor muscle training as an adjunct to a midurethral sling: a single-blind randomised controlled trial. Int Urogynecol J, 2022. 33: 809.

https://www.ncbi.nlm.nih.gov/pubmed/33660001

334.Gilling, P.J., et al. A double-blind randomized controlled trial of electromagnetic stimulation of the pelvic floor vs sham therapy in the treatment of women with stress urinary incontinence. BJU Int, 2009. 103: 1386.

https://www.ncbi.nlm.nih.gov/pubmed/19154474

335.Stewart, F., et al. Electrical stimulation with non-implanted devices for stress urinary incontinence in women. Cochrane Database Syst Rev, 2017. 12: CD012390.

https://www.ncbi.nlm.nih.gov/pubmed/29271482

336.Bo, K., et al. Single blind, randomised controlled trial of pelvic floor exercises, electrical stimulation, vaginal cones, and no treatment in management of genuine stress incontinence in women. BMJ, 1999. 318: 487.

https://www.ncbi.nlm.nih.gov/pubmed/10024253

337.Lai, X., et al. Is electroacupuncture safe and effective for treatment of stress urinary incontinence in women? A systematic review and meta-analysis. J Int Med Res, 2020. 48: 300060520948337.

https://www.ncbi.nlm.nih.gov/pubmed/33045874

338.Mettler, L., et al. Long-term treatment of atrophic vaginitis with low-dose oestradiol vaginal tablets. Maturitas, 1991. 14: 23.

https://www.ncbi.nlm.nih.gov/pubmed/1791769

339.Rahn, D.D., et al. Effects of preoperative intravaginal estrogen on pelvic floor disorder symptoms in postmenopausal women with pelvic organ prolapse. Am J Obstet Gynecol, 2023. 229: 309 e1.

https://www.ncbi.nlm.nih.gov/pubmed/37244454

340.Weber, M.A., et al. Local Oestrogen for Pelvic Floor Disorders: A Systematic Review. PLoS One, 2015. 10: e0136265.

https://www.ncbi.nlm.nih.gov/pubmed/26383760

341.Castellani, D., et al. Low-Dose Intravaginal Estriol and Pelvic Floor Rehabilitation in Post-Menopausal Stress Urinary Incontinence. Urol Int, 2015. 95: 417.

https://www.ncbi.nlm.nih.gov/pubmed/26043913

342.Morsy, S.M., et al. Does local vaginal estrogen after tension-free transobturator vaginal tape reduce overactive bladder symptoms in postmenopausal women? A prospective randomized, controlled study. Asian J Urol, 2024. 11: 86.

https://www.ncbi.nlm.nih.gov/pubmed/38312813

343.Goldstein, S.R., et al. Incidence of urinary incontinence in postmenopausal women treated with raloxifene or estrogen. Menopause, 2005. 12: 160.

https://www.ncbi.nlm.nih.gov/pubmed/15772563

344.Molander, U., et al. Effect of oral oestriol on vaginal flora and cytology and urogenital symptoms in the post-menopause. Maturitas, 1990. 12: 113.

https://www.ncbi.nlm.nih.gov/pubmed/2255263

345.Mariappan, P., et al. Duloxetine, a serotonin and noradrenaline reuptake inhibitor (SNRI) for the treatment of stress urinary incontinence: a systematic review. Eur Urol, 2007. 51: 67.

https://www.ncbi.nlm.nih.gov/pubmed/17014950

346.Li, J., et al. The role of duloxetine in stress urinary incontinence: a systematic review and meta-analysis. Int Urol Nephrol, 2013. 45: 679.

https://www.ncbi.nlm.nih.gov/pubmed/23504618

347.Ghoniem, G.M., et al. A randomized controlled trial of duloxetine alone, pelvic floor muscle training alone, combined treatment and no active treatment in women with stress urinary incontinence. J Urol, 2005. 173: 1647.

https://www.ncbi.nlm.nih.gov/pubmed/15821528

348.Bump, R.C., et al. Long-term efficacy of duloxetine in women with stress urinary incontinence. BJU Int, 2008. 102: 214.

https://www.ncbi.nlm.nih.gov/pubmed/18422764

349.Vella, M., et al. Duloxetine 1 year on: the long-term outcome of a cohort of women prescribed duloxetine. Int Urogynecol J Pelvic Floor Dysfunct, 2008. 19: 961.

https://www.ncbi.nlm.nih.gov/pubmed/18231697

350.Maund, E., et al. Considering benefits and harms of duloxetine for treatment of stress urinary incontinence: a meta-analysis of clinical study reports. CMAJ, 2017. 189: E194.

https://www.ncbi.nlm.nih.gov/pubmed/28246265

351.Acharya, N., et al. Duloxetine: meta-analyses of suicidal behaviors and ideation in clinical trials for major depressive disorder. J Clin Psychopharmacol, 2006. 26: 587.

https://www.ncbi.nlm.nih.gov/pubmed/17110815

352.Alhasso, A., et al. Adrenergic drugs for urinary incontinence in adults. Cochrane Database Syst Rev, 2005. 2005: CD001842.

https://www.ncbi.nlm.nih.gov/pubmed/16034867

353.Cumberledge, J. First Do No Harm. The report of the Independent Medicines and Medical Devices Safety Review. 2020.

https://www.immdsreview.org.uk/downloads/IMMDSReview_Web.pdf

354.Chapple, C.R., et al. Consensus Statement of the European Urology Association and the European Urogynaecological Association on the Use of Implanted Materials for Treating Pelvic Organ Prolapse and Stress Urinary Incontinence. Eur Urol, 2017. 72: 424.

https://www.ncbi.nlm.nih.gov/pubmed/28413126

355.Brazzelli, M., et al. Surgical treatments for women with stress urinary incontinence: the ESTER systematic review and economic evaluation. Health Technol Assess, 2019. 23: 1.

https://www.ncbi.nlm.nih.gov/pubmed/30929658

356.Javanbakht, M., et al. Surgical treatments for women with stress urinary incontinence: a systematic review of economic evidence. Syst Rev, 2020. 9: 85.

https://www.ncbi.nlm.nih.gov/pubmed/32312310

357.Franzen, K., et al. Surgery for urinary incontinence in women 65 years and older: a systematic review. Int Urogynecol J, 2015. 26: 1095.

https://www.ncbi.nlm.nih.gov/pubmed/25477140

358.Freites, J., et al. Laparoscopic colposuspension for urinary incontinence in women. Cochrane Database Syst Rev, 2019. 12: CD002239.

https://www.ncbi.nlm.nih.gov/pubmed/31821550

359.Glazener, C.M., et al. Anterior vaginal repair for urinary incontinence in women. Cochrane Database Syst Rev, 2017. 7: CD001755.

https://www.ncbi.nlm.nih.gov/pubmed/28759116

360.Lapitan, M.C., et al. Open retropubic colposuspension for urinary incontinence in women. Cochrane Database Syst Rev, 2016. 2: CD002912.

https://www.ncbi.nlm.nih.gov/pubmed/26878400

361.Gumus, II, et al. Laparoscopic single-port Burch colposuspension with an extraperitoneal approach and standard instruments for stress urinary incontinence: early results from a series of 15 patients. Minim Invasive Ther Allied Technol, 2013. 22: 116.

https://www.ncbi.nlm.nih.gov/pubmed/22909022

362.Guerrero, K.L., et al. A randomised controlled trial comparing TVT, Pelvicol and autologous fascial slings for the treatment of stress urinary incontinence in women. BJOG, 2010. 117: 1493.

https://www.ncbi.nlm.nih.gov/pubmed/20939862

363.Brubaker, L., et al. 5-year continence rates, satisfaction and adverse events of burch urethropexy and fascial sling surgery for urinary incontinence. J Urol, 2012. 187: 1324.

https://www.ncbi.nlm.nih.gov/pubmed/22341290

364.Kirchin, V., et al. Urethral injection therapy for urinary incontinence in women. Cochrane Database Syst Rev, 2017. 7: CD003881.

https://www.ncbi.nlm.nih.gov/pubmed/28738443

365.Hoe, V., et al. Urethral bulking agents for the treatment of stress urinary incontinence in women: A systematic review. Neurourol Urodyn, 2021. 40: 1349.

https://www.ncbi.nlm.nih.gov/pubmed/34015151

366.Ghoniem, G.M., et al. A systematic review and meta-analysis of Macroplastique for treating female stress urinary incontinence. Int Urogynecol J, 2013. 24: 27.

https://www.ncbi.nlm.nih.gov/pubmed/22699885

367.Zhao, Y., et al. Bulking agents - an analysis of 500 cases and review of the literature. Clin Exp Obstet Gynecol, 2016. 43: 666.

https://www.ncbi.nlm.nih.gov/pubmed/30074316

368.Lee, P.E., et al. Periurethral autologous fat injection as treatment for female stress urinary incontinence: a randomized double-blind controlled trial. J Urol, 2001. 165: 153.

https://www.ncbi.nlm.nih.gov/pubmed/11125386

369.Kirchin, V., et al. Urethral injection therapy for urinary incontinence in women. Cochrane Database Syst Rev, 2012: CD003881.

https://www.ncbi.nlm.nih.gov/pubmed/22336797

370.Carr, L.K., et al. Autologous muscle derived cell therapy for stress urinary incontinence: a prospective, dose ranging study. J Urol, 2013. 189: 595.

https://www.ncbi.nlm.nih.gov/pubmed/23260547

371.Maher, C.F., et al. Pubovaginal sling versus transurethral Macroplastique for stress urinary incontinence and intrinsic sphincter deficiency: a prospective randomised controlled trial. BJOG, 2005. 112: 797.

https://www.ncbi.nlm.nih.gov/pubmed/15924540

372.Itkonen Freitas, A.M., et al. Tension-Free Vaginal Tape Surgery versus Polyacrylamide Hydrogel Injection for Primary Stress Urinary Incontinence: A Randomized Clinical Trial. J Urol, 2020. 203: 372.

https://www.ncbi.nlm.nih.gov/pubmed/31479396

373.Wang, Y., et al. Safety and efficacy of vaginal laser therapy for stress urinary incontinence: a meta-analysis. Ann Palliat Med, 2021. 10: 2736.

https://www.ncbi.nlm.nih.gov/pubmed/33549008

374.Mackova, K., et al. Laser therapy for urinary incontinence and pelvic organ prolapse: a systematic review. BJOG, 2020. 127: 1338.

https://www.ncbi.nlm.nih.gov/pubmed/32333820

375.Blaganje, M., et al. Non-ablative Er:YAG laser therapy effect on stress urinary incontinence related to quality of life and sexual function: A randomized controlled trial. Eur J Obstet Gynecol Reprod Biol, 2018. 224: 153.

https://www.ncbi.nlm.nih.gov/pubmed/29604548

376.Abrams, P., et al. Synthetic vaginal tapes for stress incontinence: proposals for improved regulation of new devices in Europe. Eur Urol, 2011. 60: 1207.

https://www.ncbi.nlm.nih.gov/pubmed/21855204

377.Ford, A.A., et al. Mid-urethral sling operations for stress urinary incontinence in women. Cochrane Database Syst Rev, 2017. 7: CD006375.

https://www.ncbi.nlm.nih.gov/pubmed/28756647

378.Albo, M.E., et al. Treatment success of retropubic and transobturator mid urethral slings at 24 months. J Urol, 2012. 188: 2281.

https://www.ncbi.nlm.nih.gov/pubmed/23083653

379.Kenton, K., et al. 5-year longitudinal followup after retropubic and transobturator mid urethral slings. J Urol, 2015. 193: 203.

https://www.ncbi.nlm.nih.gov/pubmed/25158274

380.Serati, M., et al. Tension-free Vaginal Tape-Obturator for Treatment of Pure Urodynamic Stress Urinary Incontinence: Efficacy and Adverse Effects at 10-year Follow-up. Eur Urol, 2017. 71: 674.

https://www.ncbi.nlm.nih.gov/pubmed/27597239

381.Svenningsen, R., et al. Long-term follow-up of the retropubic tension-free vaginal tape procedure. Int Urogynecol J, 2013. 24: 1271.

https://www.ncbi.nlm.nih.gov/pubmed/23417313

382.Natale, F., et al. Transobturator Tape: Over 10 Years Follow-up. Urology, 2019. 129: 48.

https://www.ncbi.nlm.nih.gov/pubmed/30890420

383.Nilsson, C.G., et al. Seventeen years' follow-up of the tension-free vaginal tape procedure for female stress urinary incontinence. Int Urogynecol J, 2013. 24: 1265.

https://www.ncbi.nlm.nih.gov/pubmed/23563892

384.Morling, J.R., et al. Adverse events after first, single, mesh and non-mesh surgical procedures for stress urinary incontinence and pelvic organ prolapse in Scotland, 1997-2016: a population-based cohort study. Lancet, 2017. 389: 629.

https://www.ncbi.nlm.nih.gov/pubmed/28010993

385.Keltie, K., et al. Complications following vaginal mesh procedures for stress urinary incontinence: an 8 year study of 92,246 women. Sci Rep, 2017. 7: 12015.

https://www.ncbi.nlm.nih.gov/pubmed/28931856

386.Cartier, S., et al. The impact of surgeon operative volume on risk of reoperation within 5 years of mid-urethral sling: a systematic review. Int Urogynecol J, 2023. 34: 981.

https://www.ncbi.nlm.nih.gov/pubmed/36538044

387.Lier, D., et al. Surgical treatment of stress urinary incontinence-trans-obturator tape compared with tension-free vaginal tape-5-year follow up: an economic evaluation. BJOG, 2017. 124: 1431.

https://www.ncbi.nlm.nih.gov/pubmed/27506185

388.Ford, A.A., et al. Mid-urethral sling operations for stress urinary incontinence in women. Cochrane Database Syst Rev, 2015: CD006375.

https://www.ncbi.nlm.nih.gov/pubmed/26130017

389.Fusco, F., et al. Updated Systematic Review and Meta-analysis of the Comparative Data on Colposuspensions, Pubovaginal Slings, and Midurethral Tapes in the Surgical Treatment of Female Stress Urinary Incontinence. Eur Urol, 2017. 72: 567.

https://www.ncbi.nlm.nih.gov/pubmed/28479203

390.Cheung, R.Y., et al. Inside-out versus outside-in transobturator tension-free vaginal tape: a 5-year prospective comparative study. Int J Urol, 2014. 21: 74.

https://www.ncbi.nlm.nih.gov/pubmed/23675961

391.Abdel-Fattah, M., et al. Long-term outcomes for transobturator tension-free vaginal tapes in women with urodynamic mixed urinary incontinence. Neurourol Urodyn, 2017. 36: 902.

https://www.ncbi.nlm.nih.gov/pubmed/28028822

392.Abdel-Fattah, M., et al. Single-Incision Mini-Slings for Stress Urinary Incontinence in Women. N Engl J Med, 2022. 386: 1230.

https://www.ncbi.nlm.nih.gov/pubmed/35353961

393.Schweitzer, K.J., et al. Postoperative pain after adjustable single-incision or transobturator sling for incontinence: a randomized controlled trial. Obstet Gynecol, 2015. 125: 27.

https://www.ncbi.nlm.nih.gov/pubmed/25560100

394.Alwaal, A., et al. Female sexual function following mid-urethral slings for the treatment of stress urinary incontinence. Int J Impot Res, 2016. 28: 121.

https://www.ncbi.nlm.nih.gov/pubmed/27146350

395.Fan, Y., et al. Incontinence-specific quality of life measures used in trials of sling procedures for female stress urinary incontinence: a meta-analysis. Int Urol Nephrol, 2015. 47: 1277.

https://www.ncbi.nlm.nih.gov/pubmed/26093584

396.Wyndaele, J.J., et al. A randomized, controlled clinical trial of an intravesical pressure-attenuation balloon system for the treatment of stress urinary incontinence in females. Neurourol Urodyn, 2016. 35: 252.

https://www.ncbi.nlm.nih.gov/pubmed/25598453

397.McCammon, K., et al. Three-month primary efficacy data for the SUCCESS Trial; a phase III, multi-center, prospective, randomized, controlled study treating female stress urinary incontinence with the vesair intravesical balloon. Neurourol Urodyn, 2018. 37: 440.

https://www.ncbi.nlm.nih.gov/pubmed/29095516

398.Winkler, H., et al. Twelve-Month Efficacy and Safety Data for the "Stress Incontinence Control, Efficacy and Safety Study": A Phase III, Multicenter, Prospective, Randomized, Controlled Study Treating Female Stress Urinary Incontinence Using the Vesair Intravesical Balloon. Female Pelvic Med Reconstr Surg, 2018. 24: 222.

https://www.ncbi.nlm.nih.gov/pubmed/28953076

399.Lipp, A., et al. Mechanical devices for urinary incontinence in women. Cochrane Database Syst Rev, 2014. 2014: CD001756.

https://www.ncbi.nlm.nih.gov/pubmed/25517397

400.Shaikh, S., et al. Mechanical devices for urinary incontinence in women. Cochrane Database Syst Rev, 2006: CD001756.

https://www.ncbi.nlm.nih.gov/pubmed/16855977

401.Phe, V., et al. A systematic review of the treatment for female stress urinary incontinence by ACT(R) balloon placement (Uromedica, Irvine, CA, USA). World J Urol, 2014. 32: 495.

https://www.ncbi.nlm.nih.gov/pubmed/23783882

402.Peyronnet, B., et al. AMS-800 Artificial urinary sphincter in female patients with stress urinary incontinence: A systematic review. Neurourol Urodyn, 2019. 38 Suppl 4: S28.

https://www.ncbi.nlm.nih.gov/pubmed/30298943

403.Bakali, E., et al. Treatment of recurrent stress urinary incontinence after failed minimally invasive synthetic suburethral tape surgery in women. Cochrane Database Syst Rev, 2013: CD009407.

https://www.ncbi.nlm.nih.gov/pubmed/23450602

404.Zimmern, P.E., et al. Management of recurrent stress urinary incontinence after burch and sling procedures. Neurourol Urodyn, 2016. 35: 344.

https://www.ncbi.nlm.nih.gov/pubmed/25598512

405.Bakali, E., et al. Interventions for treating recurrent stress urinary incontinence after failed minimally invasive synthetic midurethral tape surgery in women. Cochrane Database Syst Rev, 2019. 9: CD009407.

https://www.ncbi.nlm.nih.gov/pubmed/31482580

406.Pradhan, A., et al. Effectiveness of midurethral slings in recurrent stress urinary incontinence: a systematic review and meta-analysis. Int Urogynecol J, 2012. 23: 831.

https://www.ncbi.nlm.nih.gov/pubmed/22576328

407.Agur, W., et al. Surgical treatment of recurrent stress urinary incontinence in women: a systematic review and meta-analysis of randomised controlled trials. Eur Urol, 2013. 64: 323.

https://www.ncbi.nlm.nih.gov/pubmed/23680414

408.Nikolopoulos, K.I., et al. The surgical management of recurrent stress urinary incontinence: a systematic review. Acta Obstet Gynecol Scand, 2015. 94: 568.

https://www.ncbi.nlm.nih.gov/pubmed/25737292

409.Amaye-Obu, F.A., et al. Surgical management of recurrent stress urinary incontinence: A 12-year experience. Am J Obstet Gynecol, 1999. 181: 1296.

https://www.ncbi.nlm.nih.gov/pubmed/10601904

410.Errando-Smet, C., et al. A re-adjustable sling for female recurrent stress incontinence and intrinsic sphincteric deficiency: Long-term results in 205 patients using the Remeex sling system. Neurourol Urodyn, 2018. 37: 1349.

https://www.ncbi.nlm.nih.gov/pubmed/29130569

411.Chung, E., et al. 25-year experience in the outcome of artificial urinary sphincter in the treatment of female urinary incontinence. BJU Int, 2010. 106: 1664.

https://www.ncbi.nlm.nih.gov/pubmed/20500509

412.Costa, P., et al. The use of an artificial urinary sphincter in women with type III incontinence and a negative Marshall test. J Urol, 2001. 165: 1172.

https://www.ncbi.nlm.nih.gov/pubmed/11257664

413.Heitz, M., et al. [Therapy of female urinary incontinence with the AMS 800 artificial sphincter. Indications, outcome, complications and risk factors]. Urologe A, 1997. 36: 426.

https://www.ncbi.nlm.nih.gov/pubmed/9424794

414.Vayleux, B., et al. Female urinary incontinence and artificial urinary sphincter: study of efficacy and risk factors for failure and complications. Eur Urol, 2011. 59: 1048.

https://www.ncbi.nlm.nih.gov/pubmed/21420781

415.Mandron, E., et al. Laparoscopic artificial urinary sphincter implantation for female genuine stress urinary incontinence: technique and 4-year experience in 25 patients. BJU Int, 2010. 106: 1194.

https://www.ncbi.nlm.nih.gov/pubmed/20132197

416.Roupret, M., et al. Laparoscopic approach for artificial urinary sphincter implantation in women with intrinsic sphincter deficiency incontinence: a single-centre preliminary experience. Eur Urol, 2010. 57: 499.

https://www.ncbi.nlm.nih.gov/pubmed/19346059

417.Brennand, E.A., et al. Five years after midurethral sling surgery for stress incontinence: obesity continues to have an impact on outcomes. Int Urogynecol J, 2017. 28: 621.

https://www.ncbi.nlm.nih.gov/pubmed/27686569

418.Brennand, E.A., et al. Twelve-month outcomes following midurethral sling procedures for stress incontinence: impact of obesity. BJOG, 2015. 122: 1705.

https://www.ncbi.nlm.nih.gov/pubmed/25316484

419.Moore, R.D., et al. Two-year evaluation of the MiniArc in obese versus non-obese patients for treatment of stress urinary incontinence. Int J Urol, 2013. 20: 434.

https://www.ncbi.nlm.nih.gov/pubmed/22989174

420.Moran, E., et al. Mid-term safety and efficacy of the ALTIS((R)) single-incision sling for female stress urinary incontinence: less mesh, same results. BJU Int, 2019. 123: E51.

https://www.ncbi.nlm.nih.gov/pubmed/30267560

421.Rechberger, T., et al. The clinical effectiveness of retropubic (IVS-02) and transobturator (IVS-04) midurethral slings: randomized trial. Eur Urol, 2009. 56: 24.

https://www.ncbi.nlm.nih.gov/pubmed/19285788

422.Barber, M.D., et al. Risk factors associated with failure 1 year after retropubic or transobturator midurethral slings. Am J Obstet Gynecol, 2008. 199: 666 e1.

https://www.ncbi.nlm.nih.gov/pubmed/19084098

423.Richter, H.E., et al. Predictors of treatment failure 24 months after surgery for stress urinary incontinence. J Urol, 2008. 179: 1024.

https://www.ncbi.nlm.nih.gov/pubmed/18206917

424.Campeau, L., et al. A multicenter, prospective, randomized clinical trial comparing tension-free vaginal tape surgery and no treatment for the management of stress urinary incontinence in elderly women. Neurourol Urodyn, 2007. 26: 990.

https://www.ncbi.nlm.nih.gov/pubmed/17638307

425.Chughtai, B., et al. Diagnosis, Evaluation, and Treatment of Mixed Urinary Incontinence in Women. Rev Urol, 2015. 17: 78.

https://www.ncbi.nlm.nih.gov/pubmed/27222643

426.Abrams, P., et al., Incontinence 6th Edition, ed. P. Abrams, Cardozo, L, Wagg, A, Wein, A. (Eds). Vol. 6th Edn. 2017, Bristol, UK.

https://www.ics.org/education/icspublications/icibooks/6thicibook

427.Minassian, V.A., et al. Severity of urinary incontinence and effect on quality of life in women by incontinence type. Obstet Gynecol, 2013. 121: 1083.

https://www.ncbi.nlm.nih.gov/pubmed/23635747

428.Brubaker, L., et al. Mixed incontinence: comparing definitions in women having stress incontinence surgery. Neurourol Urodyn, 2009. 28: 268.

https://www.ncbi.nlm.nih.gov/pubmed/19274758

429.Porena, M., et al. Mixed Incontinence: How Best to Manage It? Curr Bladder Dysfunct Rep, 2013. 8: 7.

https://www.ncbi.nlm.nih.gov/pubmed/23396610

430.Jung, S.Y., et al. Urethral afferent nerve activity affects the micturition reflex; implication for the relationship between stress incontinence and detrusor instability. J Urol, 1999. 162: 204.

https://www.ncbi.nlm.nih.gov/pubmed/10379788

431.Mahony, D.T., et al. Integral storage and voiding reflexes. Neurophysiologic concept of continence and micturition. Urology, 1977. 9: 95.

https://www.ncbi.nlm.nih.gov/pubmed/556658

432.Nygaard, I.E. Evidence-Based Treatment for Mixed Urinary Incontinence. JAMA, 2019. 322: 1049.

https://www.ncbi.nlm.nih.gov/pubmed/31528991

433.Myers, D.L. Female mixed urinary incontinence: a clinical review. JAMA, 2014. 311: 2007.

https://www.ncbi.nlm.nih.gov/pubmed/24846038

434.Nygaard, I.E., et al. Efficacy of pelvic floor muscle exercises in women with stress, urge, and mixed urinary incontinence. Am J Obstet Gynecol, 1996. 174: 120.

https://www.ncbi.nlm.nih.gov/pubmed/8571994

435.Kaya, S., et al. Short-term effect of adding pelvic floor muscle training to bladder training for female urinary incontinence: a randomized controlled trial. Int Urogynecol J, 2015. 26: 285.

https://www.ncbi.nlm.nih.gov/pubmed/25266357

436.Khullar, V., et al. Treatment of urge-predominant mixed urinary incontinence with tolterodine extended release: a randomized, placebo-controlled trial. Urology, 2004. 64: 269.

https://www.ncbi.nlm.nih.gov/pubmed/15302476

437.Kreder, K.J., Jr., et al. Tolterodine is equally effective in patients with mixed incontinence and those with urge incontinence alone. BJU Int, 2003. 92: 418.

https://www.ncbi.nlm.nih.gov/pubmed/12930432

438.Kelleher, C., et al. Solifenacin: as effective in mixed urinary incontinence as in urge urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct, 2006. 17: 382.

https://www.ncbi.nlm.nih.gov/pubmed/16283422

439.Staskin, D.R., et al. Short- and long-term efficacy of solifenacin treatment in patients with symptoms of mixed urinary incontinence. BJU Int, 2006. 97: 1256.

https://www.ncbi.nlm.nih.gov/pubmed/16686722

440.Takahashi, S., et al. Efficacy of mirabegron, a beta(3) -adrenoreceptor agonist, in Japanese women with overactive bladder and either urgency urinary incontinence or mixed urinary incontinence: Post-hoc analysis of pooled data from two randomized, placebo-controlled, double-blind studies. Int J Urol, 2022. 29: 7.

https://www.ncbi.nlm.nih.gov/pubmed/34605079

441.Bent, A.E., et al. Duloxetine compared with placebo for the treatment of women with mixed urinary incontinence. Neurourol Urodyn, 2008. 27: 212.

https://www.ncbi.nlm.nih.gov/pubmed/17580357

442.Bump, R.C., et al. Mixed urinary incontinence symptoms: urodynamic findings, incontinence severity, and treatment response. Obstet Gynecol, 2003. 102: 76.

https://www.ncbi.nlm.nih.gov/pubmed/12850610

443.Shirvan, M.K., et al. Tension-Free Vaginal Tape Plus Intradetrusor BOTOX® Injection Versus Tension-Free Vaginal Tape Versus Intradetrusor BOTOX Injection in Equal-Weight Mixed Urinary Incontinence: A Prospective Randomized Study. Journal of Gynecologic Surgery, 2013. 29: 235.

https://doi.org/10.1089/gyn.2012.0134

444.Chapple, C.R., et al. Terminology report from the International Continence Society (ICS) Working Group on Underactive Bladder (UAB). Neurourol Urodyn, 2018. 37: 2928.

https://www.ncbi.nlm.nih.gov/pubmed/30203560

445.Resnick, N.M., et al. The pathophysiology of urinary incontinence among institutionalized elderly persons. N Engl J Med, 1989. 320: 1.

https://www.ncbi.nlm.nih.gov/pubmed/2909873

446.Abarbanel, J., et al. Impaired detrusor contractility in community-dwelling elderly presenting with lower urinary tract symptoms. Urology, 2007. 69: 436.

https://www.ncbi.nlm.nih.gov/pubmed/17382138

447.Groutz, A., et al. Prevalence and characteristics of voiding difficulties in women: are subjective symptoms substantiated by objective urodynamic data? Urology, 1999. 54: 268.

https://www.ncbi.nlm.nih.gov/pubmed/10443723

448.Jeong, S.J., et al. Prevalence and Clinical Features of Detrusor Underactivity among Elderly with Lower Urinary Tract Symptoms: A Comparison between Men and Women. Korean J Urol, 2012. 53: 342.

https://www.ncbi.nlm.nih.gov/pubmed/22670194

449.Suskind, A.M., et al. A new look at detrusor underactivity: impaired contractility versus afferent dysfunction. Curr Urol Rep, 2009. 10: 347.

https://www.ncbi.nlm.nih.gov/pubmed/19709481

450.Abdel Raheem, A., et al. Voiding dysfunction in women: How to manage it correctly. Arab J Urol, 2013. 11: 319.

https://www.ncbi.nlm.nih.gov/pubmed/26558099

451.Osman, N.I., et al. Contemporary concepts in the aetiopathogenesis of detrusor underactivity. Nat Rev Urol, 2014. 11: 639.

https://www.ncbi.nlm.nih.gov/pubmed/25330789

452.Gammie, A., et al. Signs and Symptoms of Detrusor Underactivity: An Analysis of Clinical Presentation and Urodynamic Tests From a Large Group of Patients Undergoing Pressure Flow Studies. Eur Urol, 2016. 69: 361.

https://www.ncbi.nlm.nih.gov/pubmed/26318706

453.Uren, A.D., et al. Qualitative Exploration of the Patient Experience of Underactive Bladder. Eur Urol, 2017. 72: 402.

https://www.ncbi.nlm.nih.gov/pubmed/28400168

454.Uren, A.D., et al. The development of the ICIQ-UAB: A patient reported outcome measure for underactive bladder. Neurourol Urodyn, 2019. 38: 996.

https://www.ncbi.nlm.nih.gov/pubmed/30801826

455.Kira, S., et al. Detrusor pressures in urodynamic studies during voiding in women. Int Urogynecol J, 2017. 28: 783.

https://www.ncbi.nlm.nih.gov/pubmed/27999934

456.Osman, N.I., et al. Detrusor Underactivity and the Underactive Bladder: A Systematic Review of Preclinical and Clinical Studies. Eur Urol, 2018. 74: 633.

https://www.ncbi.nlm.nih.gov/pubmed/30139634

457.Jeong, S.J., et al. How do we diagnose detrusor underactivity? Comparison of diagnostic criteria based on an urodynamic measure. Investig Clin Urol, 2017. 58: 247.

https://www.ncbi.nlm.nih.gov/pubmed/28681034

458.Tan, T.L., et al. Which stop test is best? Measuring detrusor contractility in older females. J Urol, 2003. 169: 1023.

https://www.ncbi.nlm.nih.gov/pubmed/12576837

459.Griffiths, D.J. Assessment of detrusor contraction strength or contractility. Neurourology and Urodynamics, 2005. 10: 1.

https://doi.org/10.1002/nau.1930100102

460.Griffiths, D.J., et al. Urinary bladder function and its control in healthy females. Am J Physiol, 1986. 251: R225.

https://www.ncbi.nlm.nih.gov/pubmed/3740303

461.van Koeveringe, G.A., et al. Detrusor underactivity: a plea for new approaches to a common bladder dysfunction. Neurourol Urodyn, 2011. 30: 723.

https://www.ncbi.nlm.nih.gov/pubmed/21661020

462.Schafer, W. Analysis of bladder-outlet function with the linearized passive urethral resistance relation, linPURR, and a disease-specific approach for grading obstruction: from complex to simple. World J Urol, 1995. 13: 47.

https://www.ncbi.nlm.nih.gov/pubmed/7773317

463.Tan, T.L., et al. Stop test or pressure-flow study? Measuring detrusor contractility in older females. Neurourol Urodyn, 2004. 23: 184.

https://www.ncbi.nlm.nih.gov/pubmed/15098212

464.Ameda, K., et al. The long-term voiding function and sexual function after pelvic nerve-sparing radical surgery for rectal cancer. Int J Urol, 2005. 12: 256.

https://www.ncbi.nlm.nih.gov/pubmed/15828952

465.Espino-Strebel, E.E., et al. A comparison of the feasibility and safety of nerve-sparing radical hysterectomy with the conventional radical hysterectomy. Int J Gynecol Cancer, 2010. 20: 1274.

https://www.ncbi.nlm.nih.gov/pubmed/21495251

466.Salvatore, S., et al., Pathophysiology of urinary incontinence, faecal incontinence and pelvic organ prolapse, in Incontinence C.L. Abrams P, Wagg A, Wein A, , Editor. 2017, ICS-ICUD.

https://www.ics.org/Publications/ICI_5/INCONTINENCE.pdf

467.El Akri, M., et al. Risk of prolapse and urinary complications in adult spina bifida patients with neurogenic acontractile detrusor using clean intermittent catheterization versus Valsalva voiding. Neurourol Urodyn, 2019. 38: 269.

https://www.ncbi.nlm.nih.gov/pubmed/30311685

468.Naess, I., et al. Can maximal voluntary pelvic floor muscle contraction reduce vaginal resting pressure and resting EMG activity? Int Urogynecol J, 2018. 29: 1623.

https://www.ncbi.nlm.nih.gov/pubmed/29532122

469.Mercier, J., et al. Pelvic floor muscle training: mechanisms of action for the improvement of genitourinary syndrome of menopause. Climacteric, 2020. 23: 468.

https://www.ncbi.nlm.nih.gov/pubmed/32105155

470.Ladi-Seyedian, S., et al. Management of non-neuropathic underactive bladder in children with voiding dysfunction by animated biofeedback: a randomized clinical trial. Urology, 2015. 85: 205.

https://www.ncbi.nlm.nih.gov/pubmed/25444633

471.Bo, K. Is there evidence for pelvic floor muscle relaxation training in nonneurogenic female bladder outlet obstruction?-A narrative review. Neurourol Urodyn, 2024. n/a.

https://www.ncbi.nlm.nih.gov/pubmed/38289257

472.Prieto, J., et al. Intermittent catheterisation for long-term bladder management. Cochrane Database Syst Rev, 2014: CD006008.

https://www.ncbi.nlm.nih.gov/pubmed/25208303

473.Tradewell, M., et al. Systematic review and practice policy statements on urinary tract infection prevention in adults with spina bifida. Transl Androl Urol, 2018. 7: S205.

https://www.ncbi.nlm.nih.gov/pubmed/29928619

474.Woodbury, M.G., et al. Intermittent catheterization practices following spinal cord injury: a national survey. Can J Urol, 2008. 15: 4065.

https://www.ncbi.nlm.nih.gov/pubmed/18570710

475.Cottenden, A., et al., Management using continence products. , in Incontinence, C.L. Abrams P, Wagg A, Wein A, Editor. 2017, ICS ICUD.

https://www.ics.org/Publications/ICI_5/INCONTINENCE.pdf

476.Hakansson, M.A. Reuse versus single-use catheters for intermittent catheterization: what is safe and preferred? Review of current status. Spinal Cord, 2014. 52: 511.

https://www.ncbi.nlm.nih.gov/pubmed/24861702

477.Drake, M.J., et al., Neurological Urinary and fecal incontinence, in Incontinence, C.L. Abrams P, Wagg A, Wein A,, Editor. 2017, ICS ICUD.

https://www.ics.org/Publications/ICI_5/INCONTINENCE.pdf

478.Huber, E.R., et al. [The value of intravesical electrostimulation in the treatment of acute prolonged bladder overdistension]. Urologe A, 2007. 46: 662.

https://www.ncbi.nlm.nih.gov/pubmed/17356837

479.Barendrecht, M.M., et al. Is the use of parasympathomimetics for treating an underactive urinary bladder evidence-based? BJU Int, 2007. 99: 749.

https://www.ncbi.nlm.nih.gov/pubmed/17233798

480.Chang, S.J., et al. The effectiveness of tamsulosin in treating women with voiding difficulty. Int J Urol, 2008. 15: 981.

https://www.ncbi.nlm.nih.gov/pubmed/18721208

481.Costantini, E., et al. Open-label, longitudinal study of tamsulosin for functional bladder outlet obstruction in women. Urol Int, 2009. 83: 311.

https://www.ncbi.nlm.nih.gov/pubmed/19829032

482.Yamanishi, T., et al. Combination of a cholinergic drug and an alpha-blocker is more effective than monotherapy for the treatment of voiding difficulty in patients with underactive detrusor. Int J Urol, 2004. 11: 88.

https://www.ncbi.nlm.nih.gov/pubmed/14706012

483.Buckley, B.S., et al. Drugs for treatment of urinary retention after surgery in adults. Cochrane Database Syst Rev, 2010: CD008023.

https://www.ncbi.nlm.nih.gov/pubmed/20927768

484.Jonas, U., et al. Efficacy of sacral nerve stimulation for urinary retention: results 18 months after implantation. J Urol, 2001. 165: 15.

https://www.ncbi.nlm.nih.gov/pubmed/11125353

485.Gross, C., et al. Sacral neuromodulation for nonobstructive urinary retention: a meta-analysis. Female Pelvic Med Reconstr Surg, 2010. 16: 249.

https://www.ncbi.nlm.nih.gov/pubmed/22453352

486.Gani, J., et al. The underactive bladder: diagnosis and surgical treatment options. Transl Androl Urol, 2017. 6: S186.

https://www.ncbi.nlm.nih.gov/pubmed/28791238

487.Panicker, J.N., et al. Lower urinary tract dysfunction in the neurological patient: clinical assessment and management. Lancet Neurol, 2015. 14: 720.

https://www.ncbi.nlm.nih.gov/pubmed/26067125

488.Kuo, H.C. Recovery of detrusor function after urethral botulinum A toxin injection in patients with idiopathic low detrusor contractility and voiding dysfunction. Urology, 2007. 69: 57.

https://www.ncbi.nlm.nih.gov/pubmed/17270614

489.Kuo, H.C. Effect of botulinum a toxin in the treatment of voiding dysfunction due to detrusor underactivity. Urology, 2003. 61: 550.

https://www.ncbi.nlm.nih.gov/pubmed/12639645

490.Lee, Y.-K., et al. Therapeutic Efficacy and Quality of Life Improvement in Women with Detrusor Underactivity Following Transurethral Incision of the Bladder Neck. Urological Science, 2019. 30: 266.

https://doi.org/10.4103/uros.uros_39_19

491.Gakis, G., et al. Functional detrusor myoplasty for bladder acontractility: long-term results. J Urol, 2011. 185: 593.

https://www.ncbi.nlm.nih.gov/pubmed/21168866

492.Liao, L., et al. Randomized controlled trial of intravesical electrical stimulation for underactive bladder. BJU Int, 2023. 131: 321.

https://www.ncbi.nlm.nih.gov/pubmed/36084065

493.Malde, S., et al. Female bladder outlet obstruction: Common symptoms masking an uncommon cause. Low Urin Tract Symptoms, 2019. 11: 72.

https://www.ncbi.nlm.nih.gov/pubmed/28990728

494.Irwin, D.E., et al. Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction. BJU Int, 2011. 108: 1132.

https://www.ncbi.nlm.nih.gov/pubmed/21231991

495.Moossdorff-Steinhauser, H., et al. A Survey on Voiding Complaints in Women Presenting at a Pelvic Care Center. Curr Urol, 2019. 13: 31.

https://www.ncbi.nlm.nih.gov/pubmed/31579228

496.Kupelian, V., et al. Prevalence of lower urinary tract symptoms and effect on quality of life in a racially and ethnically diverse random sample: the Boston Area Community Health (BACH) Survey. Arch Intern Med, 2006. 166: 2381.

https://www.ncbi.nlm.nih.gov/pubmed/17130393

497.Haylen, B.T., et al. Has the true prevalence of voiding difficulty in urogynecology patients been underestimated? Int Urogynecol J Pelvic Floor Dysfunct, 2007. 18: 53.

https://www.ncbi.nlm.nih.gov/pubmed/16596458

498.Hoffman, D.S., et al. Female Bladder Outlet Obstruction. Curr Urol Rep, 2016. 17: 31.

https://www.ncbi.nlm.nih.gov/pubmed/26902625

499.Sussman, R.D., et al. Primary Bladder Neck Obstruction. Rev Urol, 2019. 21: 53.

https://www.ncbi.nlm.nih.gov/pubmed/31768132

500.Brucker, B.M., et al. Comparison of urodynamic findings in women with anatomical versus functional bladder outlet obstruction. Female Pelvic Med Reconstr Surg, 2013. 19: 46.

https://www.ncbi.nlm.nih.gov/pubmed/23321659

501.Nitti, V.W. Primary bladder neck obstruction in men and women. Rev Urol, 2005. 7 Suppl 8: S12.

https://www.ncbi.nlm.nih.gov/pubmed/16985885

502.Panicker, J.N., et al. Do we understand voiding dysfunction in women? Current understanding and future perspectives: ICI-RS 2017. Neurourol Urodyn, 2018. 37: S75.

https://www.ncbi.nlm.nih.gov/pubmed/30133794

503.Karmakar, D., et al. Current concepts in voiding dysfunction and dysfunctional voiding: A review from a urogynaecologist's perspective. J Midlife Health, 2014. 5: 104.

https://www.ncbi.nlm.nih.gov/pubmed/25316994

504.Karmarkar, R., et al. Gynaecological pathology in women with Fowler's syndrome. Eur J Obstet Gynecol Reprod Biol, 2015. 194: 54.

https://www.ncbi.nlm.nih.gov/pubmed/26340452

505.Panesar, K. Drug-Induced Urinary Incontinence. US Pharm, 2014. 39: 24.

https://www.uspharmacist.com/article/druginduced-urinary-incontinence

506.Groutz, A., et al. Bladder outlet obstruction in women: definition and characteristics. Neurourol Urodyn, 2000. 19: 213.

https://www.ncbi.nlm.nih.gov/pubmed/10797578

507.Rosenblum, N., et al. Voiding dysfunction in young, nulliparous women: symptoms and urodynamic findings. Int Urogynecol J Pelvic Floor Dysfunct, 2004. 15: 373.

https://www.ncbi.nlm.nih.gov/pubmed/15278258

508.Massey, J.A., et al. Obstructed voiding in the female. Br J Urol, 1988. 61: 36.

https://www.ncbi.nlm.nih.gov/pubmed/3342298

509.Hsiao, S.M., et al. Videourodynamic Studies of Women with Voiding Dysfunction. Sci Rep, 2017. 7: 6845.

https://www.ncbi.nlm.nih.gov/pubmed/28754926

510.Gravina, G.L., et al. Urodynamic obstruction in women with stress urinary incontinence--do nonintubated uroflowmetry and symptoms aid diagnosis? J Urol, 2007. 178: 959.

https://www.ncbi.nlm.nih.gov/pubmed/17632142

511.Cheng, Y., et al. A novel predictive model for noninvasively diagnosing bladder outlet obstruction in female patients based on clinical features and uroflowmetry parameters. Int J Gynaecol Obstet, 2024. 166: 655.

https://www.ncbi.nlm.nih.gov/pubmed/38415782

512.Chen, Y.Z., et al. Bladder Sonomorphological Tests in Diagnosing Bladder Outlet Obstruction in Patients with Lower Urinary Tract Symptoms: A Systematic Review and Meta-Analysis. Urol Int, 2023. 107: 327.

https://www.ncbi.nlm.nih.gov/pubmed/34903702

513.Qian, M., et al. Value of Real-Time Shear Wave Elastography Versus Acoustic Radiation Force Impulse Imaging in the Diagnosis of Female Bladder Neck Obstruction. J Ultrasound Med, 2019. 38: 2427.

https://www.ncbi.nlm.nih.gov/pubmed/30680774

514.Lorenzo, A.J., et al. Endorectal coil magnetic resonance imaging for diagnosis of urethral and periurethral pathologic findings in women. Urology, 2003. 61: 1129.

https://www.ncbi.nlm.nih.gov/pubmed/12809879

515.Worman, R., et al. Methods used to investigate tone of pelvic floor muscles in pelvic health conditions: A systematic review. Continence, 2023. 6: 100593.

https://doi.org/10.1016/j.cont.2023.100593

516.Worman, R.S., et al. Evidence for increased tone or overactivity of pelvic floor muscles in pelvic health conditions: a systematic review. Am J Obstet Gynecol, 2023. 228: 657.

https://www.ncbi.nlm.nih.gov/pubmed/37272325

517.Webb, R.J., et al. Electromyographic abnormalities in the urethral and anal sphincters of women with idiopathic retention of urine. Br J Urol, 1992. 70: 22.

https://www.ncbi.nlm.nih.gov/pubmed/1638369

518.Fowler, C.J., et al. Abnormal electromyographic activity of the urethral sphincter, voiding dysfunction, and polycystic ovaries: a new syndrome? BMJ, 1988. 297: 1436.

https://www.ncbi.nlm.nih.gov/pubmed/3147005

519.Tawadros, C., et al. External urethral sphincter electromyography in asymptomatic women and the influence of the menstrual cycle. BJU Int, 2015. 116: 423.

https://www.ncbi.nlm.nih.gov/pubmed/25600712

520.Osman, N.I., et al. Contemporary surgical management of female urethral stricture disease. Curr Opin Urol, 2015. 25: 341.

https://www.ncbi.nlm.nih.gov/pubmed/26049879

521.Rademakers, K., et al. Male bladder outlet obstruction: Time to re-evaluate the definition and reconsider our diagnostic pathway? ICI-RS 2015. Neurourol Urodyn, 2017. 36: 894.

https://www.ncbi.nlm.nih.gov/pubmed/28444709

522.Meier, K., et al. Female bladder outlet obstruction: an update on diagnosis and management. Curr Opin Urol, 2016. 26: 334.

https://www.ncbi.nlm.nih.gov/pubmed/27214578

523.Blaivas, J.G., et al. Bladder outlet obstruction nomogram for women with lower urinary tract symptomatology. Neurourol Urodyn, 2000. 19: 553.

https://www.ncbi.nlm.nih.gov/pubmed/11002298

524.Akikwala, T.V., et al. Comparison of diagnostic criteria for female bladder outlet obstruction. J Urol, 2006. 176: 2093.

https://www.ncbi.nlm.nih.gov/pubmed/17070266

525.Solomon, E., et al. Developing and validating a new nomogram for diagnosing bladder outlet obstruction in women. Neurourol Urodyn, 2018. 37: 368.

https://www.ncbi.nlm.nih.gov/pubmed/28666055

526.Lindsay, J., et al. Treatment validation of the Solomon-Greenwell nomogram for female bladder outlet obstruction. Neurourol Urodyn, 2020. 39: 1371.

https://www.ncbi.nlm.nih.gov/pubmed/32249980

527.Cormier, L., et al. Diagnosis of female bladder outlet obstruction and relevance of the parameter area under the curve of detrusor pressure during voiding: preliminary results. J Urol, 2002. 167: 2083.

https://www.ncbi.nlm.nih.gov/pubmed/11956445

528.Romanzi, L.J., et al. The effect of genital prolapse on voiding. J Urol, 1999. 161: 581.

https://www.ncbi.nlm.nih.gov/pubmed/9915453

529.Bailey, C., et al. Conservative management as an initial approach for post-operative voiding dysfunction. Eur J Obstet Gynecol Reprod Biol, 2012. 160: 106.

https://www.ncbi.nlm.nih.gov/pubmed/22000341

530.Madjar, S., et al. A remote controlled intraurethral insert for artificial voiding: a new concept for treating women with voiding dysfunction. J Urol, 1999. 161: 895.

https://www.ncbi.nlm.nih.gov/pubmed/10022709

531.Madjar, S., et al. Long-term follow-up of the in-flowtrade mark intraurethral insert for the treatment of women with voiding dysfunction. Eur Urol, 2000. 38: 161.

https://www.ncbi.nlm.nih.gov/pubmed/10895007

532.Fletcher, S.G., et al. Demographic and urodynamic factors associated with persistent OAB after anterior compartment prolapse repair. Neurourol Urodyn, 2010. 29: 1414.

https://www.ncbi.nlm.nih.gov/pubmed/20623545

533.Espuna-Pons, M., et al. Cough stress tests to diagnose stress urinary incontinence in women with pelvic organ prolapse with indication for surgical treatment. Neurourol Urodyn, 2020. 39: 819.

https://www.ncbi.nlm.nih.gov/pubmed/32040873

534.Togo, M., et al. Lower urinary tract function improves after laparoscopic sacrocolpopexy for elderly patients with pelvic organ prolapse. Low Urin Tract Symptoms, 2020. 12: 260.

https://www.ncbi.nlm.nih.gov/pubmed/32347664

535.Osman, N.I., et al. A systematic review of surgical techniques used in the treatment of female urethral stricture. Eur Urol, 2013. 64: 965.

https://www.ncbi.nlm.nih.gov/pubmed/23937829

536.Basu, M., et al. Urethral dilatation: Is there any benefit over cystoscopy and distension? A randomized trial in women with overactive bladder symptoms. Neurourol Urodyn, 2014. 33: 283.

https://www.ncbi.nlm.nih.gov/pubmed/23636866

537.Heidari, F., et al. On demand urethral dilatation versus intermittent urethral dilatation: results and complications in women with urethral stricture. Nephrourol Mon, 2014. 6: e15212.

https://www.ncbi.nlm.nih.gov/pubmed/24783171

538.Popat, S., et al. Long-term management of luminal urethral stricture in women. Int Urogynecol J, 2016. 27: 1735.

https://www.ncbi.nlm.nih.gov/pubmed/27026141

539.Grivas, N., et al. The effectiveness of otis urethrotomy combined with six weeks urethral dilations until 40 Fr in the treatment of bladder outlet obstruction in women: a prospective study. Urol J, 2014. 10: 1063.

https://www.ncbi.nlm.nih.gov/pubmed/24469651

540.Haq, S., et al. Comparison of effectiveness of clean intermittent self catheterization with no catheterization after internal optical urethrotomy for urethral stricture. Journal of Postgraduate Medical Institute, 2019. 33: 64.

https://jpmi.org.pk/index.php/jpmi/article/view/2395

541.Jackson, M.J., et al. Intermittent self-dilatation for urethral stricture disease in males. Cochrane Database Syst Rev, 2014. 2014: CD010258.

https://www.ncbi.nlm.nih.gov/pubmed/25523166

542.Choudhury, A. Incisional treatment of obstruction of the female bladder neck. Ann R Coll Surg Engl, 1978. 60: 404.

https://www.ncbi.nlm.nih.gov/pubmed/697298

543.Zhang, P., et al. Bladder neck incision for female bladder neck obstruction: long-term outcomes. Urology, 2014. 83: 762.

https://www.ncbi.nlm.nih.gov/pubmed/24680443

544.Fu, Q., et al. Transurethral incision of the bladder neck using KTP in the treatment of bladder neck obstruction in women. Urol Int, 2009. 82: 61.

https://www.ncbi.nlm.nih.gov/pubmed/19172099

545.Shen, W., et al. Controlled transurethral resection and incision of the bladder neck to treat female primary bladder neck obstruction: Description of a novel surgical procedure. Int J Urol, 2016. 23: 491.

https://www.ncbi.nlm.nih.gov/pubmed/27037830

546.Jin, X.B., et al. Modified transurethral incision for primary bladder neck obstruction in women: a method to improve voiding function without urinary incontinence. Urology, 2012. 79: 310.

https://www.ncbi.nlm.nih.gov/pubmed/22310746

547.Hoag, N., et al. Surgical management of female urethral strictures. Transl Androl Urol, 2017. 6: S76.

https://www.ncbi.nlm.nih.gov/pubmed/28791225

548.Nayyar, R., et al. A Novel Anterior Bladder Tube for Traumatic Bladder Neck Contracture in Females: Initial Results. Urology, 2020. 139: 201.

https://www.ncbi.nlm.nih.gov/pubmed/32061615

549.Hampson, L.A., et al. Dorsal buccal graft urethroplasty in female urethral stricture disease: a multi-center experience. Transl Androl Urol, 2019. 8: S6.

https://www.ncbi.nlm.nih.gov/pubmed/31143666

550.Gomez, R.G., et al. Female urethral reconstruction: dorsal buccal mucosa graft onlay. World J Urol, 2020. 38: 3047.

https://www.ncbi.nlm.nih.gov/pubmed/31542825

551.Lumen, N.e.a., European Association of Urology Guidelines on Urethral Strictures, in EAU Guidelines published at the 39th EAU Annual Congress, Paris 20234. 2024: Arnhem, The Netherlands.

https://uroweb.org/guidelines/urethral-strictures

552.Mouracade, P., et al. Transvaginal tape lysis for urinary obstruction after suburethral tape placement. When to do an immediate replacement? Int Urogynecol J Pelvic Floor Dysfunct, 2008. 19: 1271.

https://www.ncbi.nlm.nih.gov/pubmed/18461268

553.McCrery, R., et al. Transvaginal urethrolysis for obstruction after antiincontinence surgery. Int Urogynecol J Pelvic Floor Dysfunct, 2007. 18: 627.

https://www.ncbi.nlm.nih.gov/pubmed/17036167

554.Giannis, G., et al. Can urethrolysis resolve outlet obstruction related symptoms after Burch colposuspension for stress urinary incontinence? Eur J Obstet Gynecol Reprod Biol, 2015. 195: 103.

https://www.ncbi.nlm.nih.gov/pubmed/26512435

555.Leng, W.W., et al. Delayed treatment of bladder outlet obstruction after sling surgery: association with irreversible bladder dysfunction. J Urol, 2004. 172: 1379.

https://www.ncbi.nlm.nih.gov/pubmed/15371849

556.Agnew, G., et al. Functional outcomes for surgical revision of synthetic slings performed for voiding dysfunction: a retrospective study. Eur J Obstet Gynecol Reprod Biol, 2012. 163: 113.

https://www.ncbi.nlm.nih.gov/pubmed/22579029

557.Van den Broeck, T., et al. The value of surgical release after obstructive anti-incontinence surgery: An aid for clinical decision making. Neurourol Urodyn, 2015. 34: 736.

https://www.ncbi.nlm.nih.gov/pubmed/25212178

558.Rautenberg, O., et al. Ultrasound and early tape mobilization--a practical solution for treating postoperative voiding dysfunction. Neurourol Urodyn, 2014. 33: 1147.

https://www.ncbi.nlm.nih.gov/pubmed/23818418

559.Koh, J.S., et al. Comparison of alpha-blocker, extracorporeal magnetic stimulation alone and in combination in the management of female bladder outlet obstruction. Int Urogynecol J, 2011. 22: 849.

https://www.ncbi.nlm.nih.gov/pubmed/21107813

560.Sigala, S., et al. Alpha1 adrenoceptor subtypes in human urinary bladder: sex and regional comparison. Life Sci, 2004. 76: 417.

https://www.ncbi.nlm.nih.gov/pubmed/15530504

561.Kim, D.K., et al. Alpha-1 Adrenergic Receptor Blockers for the Treatment of Lower Urinary Tract Symptoms in Women: A Systematic Review and Meta-Analysis. Int Neurourol J, 2019. 23: 56.

https://www.ncbi.nlm.nih.gov/pubmed/30943695

562.Boyd, K., et al. alpha-adrenergic blockers for the treatment of lower-urinary-tract symptoms and dysfunction in women. Ann Pharmacother, 2014. 48: 711.

https://www.ncbi.nlm.nih.gov/pubmed/24615630

563.Meyer, L.E., et al. Tamsulosin for voiding dysfunction in women. Int Urol Nephrol, 2012. 44: 1649.

https://www.ncbi.nlm.nih.gov/pubmed/22983886

564.Pischedda, A., et al. Use of alpha1-blockers in female functional bladder neck obstruction. Urol Int, 2005. 74: 256.

https://www.ncbi.nlm.nih.gov/pubmed/15812214

565.Kessler, T.M., et al. The effect of terazosin on functional bladder outlet obstruction in women: a pilot study. J Urol, 2006. 176: 1487.

https://www.ncbi.nlm.nih.gov/pubmed/16952666

566.Athanasopoulos, A., et al. Effect of alfuzosin on female primary bladder neck obstruction. Int Urogynecol J Pelvic Floor Dysfunct, 2009. 20: 217.

https://www.ncbi.nlm.nih.gov/pubmed/18982236

567.Lee, Y.S., et al. Efficacy of an Alpha-Blocker for the Treatment of Nonneurogenic Voiding Dysfunction in Women: An 8-Week, Randomized, Double-Blind, Placebo-Controlled Trial. Int Neurourol J, 2018. 22: 30.

https://www.ncbi.nlm.nih.gov/pubmed/29609420

568.Hajebrahimi, S., et al. Effect of tamsulosin versus prazosin on clinical and urodynamic parameters in women with voiding difficulty: a randomized clinical trial. Int J Gen Med, 2011. 4: 35.

https://www.ncbi.nlm.nih.gov/pubmed/21403790

569.Xu, D., et al. Dysfunctional voiding confirmed by transdermal perineal electromyography, and its effective treatment with baclofen in women with lower urinary tract symptoms: a randomized double-blind placebo-controlled crossover trial. BJU Int, 2007. 100: 588.

https://www.ncbi.nlm.nih.gov/pubmed/17511770

570.Datta, S.N., et al. Results of double-blind placebo-controlled crossover study of sildenafil citrate (Viagra) in women suffering from obstructed voiding or retention associated with the primary disorder of sphincter relaxation (Fowler's Syndrome). Eur Urol, 2007. 51: 489.

https://www.ncbi.nlm.nih.gov/pubmed/16884844

571.Rosario, D.J., et al. Effects of intravenous thyrotropin-releasing hormone on urethral closure pressure in females with voiding dysfunction. Eur Urol, 1995. 28: 64.

https://www.ncbi.nlm.nih.gov/pubmed/8521898

572.Kao, Y.L., et al. The Therapeutic Effects and Pathophysiology of Botulinum Toxin A on Voiding Dysfunction Due to Urethral Sphincter Dysfunction. Toxins (Basel), 2019. 11.

https://www.ncbi.nlm.nih.gov/pubmed/31847090

573.Jiang, Y.H., et al. OnabotulinumtoxinA Urethral Sphincter Injection as Treatment for Non-neurogenic Voiding Dysfunction - A Randomized, Double-Blind, Placebo-Controlled Study. Sci Rep, 2016. 6: 38905.

https://www.ncbi.nlm.nih.gov/pubmed/27958325

574.Gavi, F., et al. Efficacy of transurethral botulinum toxin A injections for bladder outlet obstruction: A systematic review and meta-analysis. Urologia, 2024. 91: 468.

https://www.ncbi.nlm.nih.gov/pubmed/38372240

575.Pradhan, A.A. Botulinum toxin: An emerging therapy in female bladder outlet obstruction. Indian J Urol, 2009. 25: 318.

https://www.ncbi.nlm.nih.gov/pubmed/19881122

576.Pal, A.K., et al. Outcomes of bladder neck botulinum toxin injection for female primary bladder neck obstruction-does subjective improvement correlate with an objective assessment? Int Urogynecol J, 2023. 34: 1049.

https://www.ncbi.nlm.nih.gov/pubmed/35939098

577.Datta, S.N., et al. Sacral neurostimulation for urinary retention: 10-year experience from one UK centre. BJU Int, 2008. 101: 192.

https://www.ncbi.nlm.nih.gov/pubmed/17970787

578.Peeters, K., et al. Long-term follow-up of sacral neuromodulation for lower urinary tract dysfunction. BJU Int, 2014. 113: 789.

https://www.ncbi.nlm.nih.gov/pubmed/24238278

579.Nasri, J., et al. Development of a predictive tool for sacral nerve modulation implantation in the treatment of non-obstructive urinary retention and/or slow urinary stream: a study from the Neuro-Urology Committee of the French Association of Urology. World J Urol, 2023. 41: 3075.

https://www.ncbi.nlm.nih.gov/pubmed/37783844

580.Hashim, H., et al. International Continence Society (ICS) report on the terminology for nocturia and nocturnal lower urinary tract function. Neurourol Urodyn, 2019. 38: 499.

https://www.ncbi.nlm.nih.gov/pubmed/30644584

581.Bedretdinova, D., et al. What Is the Most Effective Treatment for Nocturia or Nocturnal Incontinence in Adult Women? Eur Urol Focus, 2021. 7: 453.

https://www.ncbi.nlm.nih.gov/pubmed/32061540

582.Bosch, J.L., et al. The prevalence and causes of nocturia. J Urol, 2010. 184: 440.

https://www.ncbi.nlm.nih.gov/pubmed/20620395

583.Burgio, K.L., et al. Prevalence and correlates of nocturia in community-dwelling older adults. J Am Geriatr Soc, 2010. 58: 861.

https://www.ncbi.nlm.nih.gov/pubmed/20406317

584.Fitzgerald, M.P., et al. The association of nocturia with cardiac disease, diabetes, body mass index, age and diuretic use: results from the BACH survey. J Urol, 2007. 177: 1385.

https://www.ncbi.nlm.nih.gov/pubmed/17382738

585.Rahman, S.N., et al. Phenotyping the Association between Nocturia and Hypertension: A Systematic Review and Meta-Analysis. J Urol, 2021. 205: 1577.

https://www.ncbi.nlm.nih.gov/pubmed/33081593

586.Pesonen, J.S., et al. The Impact of Nocturia on Mortality: A Systematic Review and Meta-Analysis. J Urol, 2020. 203: 486.

https://www.ncbi.nlm.nih.gov/pubmed/31364920

587.Chapple, C.R., et al. The patient burden of nocturnal polyuria in the United States: Results from the epidemiology of nocturnal polyuria (EpiNP) study. Neurourol Urodyn, 2023. 42: 573.

https://www.ncbi.nlm.nih.gov/pubmed/36655731

588.Smith, A.L., et al. Outcomes of pharmacological management of nocturia with non-antidiuretic agents: does statistically significant equal clinically significant? BJU Int, 2011. 107: 1550.

https://www.ncbi.nlm.nih.gov/pubmed/21518417

589.Gordon, D.J., et al. Management Strategies for Nocturia. Curr Urol Rep, 2019. 20: 75.

https://www.ncbi.nlm.nih.gov/pubmed/31707521

590.Pauwaert, K., et al. Nocturia through the menopausal transition and beyond: a narrative review. Int Urogynecol J, 2021. 32: 1097.

https://www.ncbi.nlm.nih.gov/pubmed/33439278

591.Weiss, J.P., et al. Management of Nocturia and Nocturnal Polyuria. Urology, 2019. 133S: 24.

https://www.ncbi.nlm.nih.gov/pubmed/31586470

592.Reyes, P.B.G., et al. Implications of Cardiovascular Disease for Assessment and Treatment of Nocturia in Primary Care: Systematic Review and Nominal Group Technique Consensus. Eur Urol Focus, 2022. 8: 26.

https://www.ncbi.nlm.nih.gov/pubmed/35031352

593.Abraham, L., et al. Development and validation of a quality-of-life measure for men with nocturia. Urology, 2004. 63: 481.

https://www.ncbi.nlm.nih.gov/pubmed/15028442

594.Holm-Larsen, T., et al. The Nocturia Impact Diary: a self-reported impact measure to complement the voiding diary. Value Health, 2014. 17: 696.

https://www.ncbi.nlm.nih.gov/pubmed/25236993

595.Bower, W.F., et al. TANGO - a screening tool to identify comorbidities on the causal pathway of nocturia. BJU Int, 2017. 119: 933.

https://www.ncbi.nlm.nih.gov/pubmed/28075514

596.Smith, M., et al. Evaluation and Treatment in Urology for Nocturia Caused by Nonurological Mechanisms: Guidance from the PLANET Study. Eur Urol Focus, 2022. 8: 89.

https://www.ncbi.nlm.nih.gov/pubmed/35101453

597.van Kerrebroeck, P., et al. The standardisation of terminology in nocturia: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn, 2002. 21: 179.

https://www.ncbi.nlm.nih.gov/pubmed/11857672

598.Denys, M.A., et al. ICI-RS 2015-Is a better understanding of sleep the key in managing nocturia? Neurourol Urodyn, 2018. 37: 2048.

https://www.ncbi.nlm.nih.gov/pubmed/27653805

599.Dawson, S., et al. Assessment and Treatment of Nocturia in Endocrine Disease in a Primary Care Setting: Systematic Review and Nominal Group Technique Consensus. Eur Urol Focus, 2022. 8: 52.

https://www.ncbi.nlm.nih.gov/pubmed/34996740

600.Papworth, E., et al. Association of Sleep Disorders with Nocturia: A Systematic Review and Nominal Group Technique Consensus on Primary Care Assessment and Treatment. Eur Urol Focus, 2022. 8: 42.

https://www.ncbi.nlm.nih.gov/pubmed/35027331

601.Ridgway, A., et al. Nocturia and Chronic Kidney Disease: Systematic Review and Nominal Group Technique Consensus on Primary Care Assessment and Treatment. Eur Urol Focus, 2022. 8: 18.

https://www.ncbi.nlm.nih.gov/pubmed/35031353

602.Johnson, T.M., 2nd, et al. Effects of behavioral and drug therapy on nocturia in older incontinent women. J Am Geriatr Soc, 2005. 53: 846.

https://www.ncbi.nlm.nih.gov/pubmed/15877562

603.Aslan, E., et al. Bladder training and Kegel exercises for women with urinary complaints living in a rest home. Gerontology, 2008. 54: 224.

https://www.ncbi.nlm.nih.gov/pubmed/18483451

604.Lo, S.K., et al. Additive Effect of Interferential Therapy Over Pelvic Floor Exercise Alone in the Treatment of Female Urinary Stress and Urge Incontinence: A Randomized Controlled Trial. Hong Kong Physiotherapy Journal, 2003. 21: 37.

https://doi.org/10.1016/S1013-7025(09)70038-7

605.Fitzgerald, M.P., et al. Nocturia, nocturnal incontinence prevalence, and response to anticholinergic and behavioral therapy. Int Urogynecol J Pelvic Floor Dysfunct, 2008. 19: 1545.

https://www.ncbi.nlm.nih.gov/pubmed/18704249

606.Weiss, J.P., et al. Excessive nocturnal urine production is a major contributing factor to the etiology of nocturia. J Urol, 2011. 186: 1358.

https://www.ncbi.nlm.nih.gov/pubmed/21855948

607.Kyoda, Y., et al. Does cognitive behavioral therapy using a self-check sheet improve night-time frequency in patients with nocturia? Results of a multicenter randomized controlled trial. Int J Urol, 2021. 28: 444.

https://www.ncbi.nlm.nih.gov/pubmed/33458939

608.But, I., et al. Functional magnetic stimulation for mixed urinary incontinence. J Urol, 2005. 173: 1644.

https://www.ncbi.nlm.nih.gov/pubmed/15821527

609.Wang, T., et al. The Efficacy of Continuous Positive Airway Pressure Therapy on Nocturia in Patients With Obstructive Sleep Apnea: A Systematic Review and Meta-Analysis. Int Neurourol J, 2015. 19: 178.

https://www.ncbi.nlm.nih.gov/pubmed/26620900

610.Di Bello, F., et al. "Nocturia and obstructive sleep apnea syndrome: A systematic review". Sleep Med Rev, 2023. 69: 101787.

https://www.ncbi.nlm.nih.gov/pubmed/37167825

611.Hilton, P., et al. The use of desmopressin (DDAVP) in nocturnal urinary frequency in the female. Br J Urol, 1982. 54: 252.

https://www.ncbi.nlm.nih.gov/pubmed/7049302

612.Lose, G., et al. Efficacy of desmopressin (Minirin) in the treatment of nocturia: a double-blind placebo-controlled study in women. Am J Obstet Gynecol, 2003. 189: 1106.

https://www.ncbi.nlm.nih.gov/pubmed/14586363

613.Yamaguchi, O., et al. Gender difference in efficacy and dose response in Japanese patients with nocturia treated with four different doses of desmopressin orally disintegrating tablet in a randomized, placebo-controlled trial. BJU Int, 2013. 111: 474.

https://www.ncbi.nlm.nih.gov/pubmed/23046147

614.Rovner, E.S., et al. Low-dose Desmopressin and Tolterodine Combination Therapy for Treating Nocturia in Women with Overactive Bladder: A Double-blind, Randomized, Controlled Study. Low Urin Tract Symptoms, 2018. 10: 221.

https://www.ncbi.nlm.nih.gov/pubmed/28560762

615.Rembratt, A., et al. Desmopressin treatment in nocturia; an analysis of risk factors for hyponatremia. Neurourol Urodyn, 2006. 25: 105.

https://www.ncbi.nlm.nih.gov/pubmed/16304673

616.Yuan, Z., et al. Comparison of Tolterodine with Estazolam versus Tolterodine alone for the treatment of women with overactive Bladder Syndrome and Nocturia: A non-randomized prospective comparative study. Pakistan Journal of Medical Sciences Online, 2011. 27: 763.

https://pjms.com.pk/index.php/pjms/article/view/899/228

617.Suzuki, T., et al. Effect of oxybutynin patch versus mirabegron on nocturia-related quality of life in female overactive bladder patients: A multicenter randomized trial. Int J Urol, 2021. 28: 944.

https://www.ncbi.nlm.nih.gov/pubmed/34053119

618.Lose, G., et al. Oestradiol-releasing vaginal ring versus oestriol vaginal pessaries in the treatment of bothersome lower urinary tract symptoms. BJOG, 2000. 107: 1029.

https://www.ncbi.nlm.nih.gov/pubmed/10955437

619.Pauwaert, K., et al. Does hormonal therapy affect the bladder or the kidney in postmenopausal women with and without nocturnal polyuria: Results of a pilot trial? Maturitas, 2022. 160: 61.

https://www.ncbi.nlm.nih.gov/pubmed/35550708

620.Reynard, J.M., et al. A novel therapy for nocturnal polyuria: a double-blind randomized trial of frusemide against placebo. Br J Urol, 1998. 81: 215.

https://www.ncbi.nlm.nih.gov/pubmed/9488061

621.Burke, C.A., et al. Melatonin and melatonin receptor agonists in the treatment of nocturia: A systematic review. Neurourol Urodyn, 2024. 43: 826.

https://www.ncbi.nlm.nih.gov/pubmed/38456646

622.Leerasiri, P., et al. Effectiveness of melatonin for the treatment of nocturia: a randomized controlled trial. Int Urogynecol J, 2023. 34: 485.

https://www.ncbi.nlm.nih.gov/pubmed/35596803

623.Plotti, F., et al. Role of Protopine and Nuciferine in the Management of Nocturia, Urgency, and Dysuria in Pre- and Postmenopausal Women: A Prospective Pilot Study. Gynecol Obstet Invest, 2023. 88: 47.

https://www.ncbi.nlm.nih.gov/pubmed/36535262

624.Choi, B., et al. The Impact of Bariatric Surgery on Nocturia Symptoms: a Systematic Review and Meta-Analysis. Obes Surg, 2022. 32: 3150.

https://www.ncbi.nlm.nih.gov/pubmed/35864289

625.Cameron, A.P. Systematic review of lower urinary tract symptoms occurring with pelvic organ prolapse. Arab J Urol, 2019. 17: 23.

https://www.ncbi.nlm.nih.gov/pubmed/33110659

626.Wu, J.M., et al. Lifetime risk of stress urinary incontinence or pelvic organ prolapse surgery. Obstet Gynecol, 2014. 123: 1201.

https://www.ncbi.nlm.nih.gov/pubmed/24807341

627.Vergeldt, T.F., et al. Risk factors for pelvic organ prolapse and its recurrence: a systematic review. Int Urogynecol J, 2015. 26: 1559.

https://www.ncbi.nlm.nih.gov/pubmed/25966804

628.DeLancey, J.O. What's new in the functional anatomy of pelvic organ prolapse? Curr Opin Obstet Gynecol, 2016. 28: 420.

https://www.ncbi.nlm.nih.gov/pubmed/27517338

629.Bo, K., et al. Strenuous physical activity, exercise, and pelvic organ prolapse: a narrative scoping review. Int Urogynecol J, 2023. 34: 1153.

https://www.ncbi.nlm.nih.gov/pubmed/36692525

630.Kowalski, J.T., et al. Natural history of lower urinary tract symptoms in treatment-seeking women with pelvic organ prolapse; the Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN). Am J Obstet Gynecol, 2022. 227: 875 e1.

https://www.ncbi.nlm.nih.gov/pubmed/35934118

631.de Boer, T.A., et al. Pelvic organ prolapse and overactive bladder. Neurourol Urodyn, 2010. 29: 30.

https://www.ncbi.nlm.nih.gov/pubmed/20025017

632.Chen, A., et al. Management of Postoperative Lower Urinary Tract Symptoms (LUTS) After Pelvic Organ Prolapse (POP) Repair. Curr Urol Rep, 2018. 19: 74.

https://www.ncbi.nlm.nih.gov/pubmed/30043287

633.Harvey, M.A., et al. International Urogynecology Consultation Chapter 1 Committee 5: relationship of pelvic organ prolapse to associated pelvic floor dysfunction symptoms: lower urinary tract, bowel, sexual dysfunction and abdominopelvic pain. Int Urogynecol J, 2021. 32: 2575.

https://www.ncbi.nlm.nih.gov/pubmed/34338825

634.Bump, R.C., et al. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol, 1996. 175: 10.

https://www.ncbi.nlm.nih.gov/pubmed/8694033

635.Theofrastous, J.P., et al. The clinical evaluation of pelvic floor dysfunction. Obstet Gynecol Clin North Am, 1998. 25: 783.

https://www.ncbi.nlm.nih.gov/pubmed/9921557

636.Ellerkmann, R.M., et al. Correlation of symptoms with location and severity of pelvic organ prolapse. Am J Obstet Gynecol, 2001. 185: 1332.

https://www.ncbi.nlm.nih.gov/pubmed/11744905

637.Grob, A.T.M., et al. Underestimation of pelvic organ prolapse in the supine straining position, based on magnetic resonance imaging findings. Int Urogynecol J, 2019. 30: 1939.

https://www.ncbi.nlm.nih.gov/pubmed/30656361

638.Visco, A.G., et al. The role of preoperative urodynamic testing in stress-continent women undergoing sacrocolpopexy: the Colpopexy and Urinary Reduction Efforts (CARE) randomized surgical trial. Int Urogynecol J Pelvic Floor Dysfunct, 2008. 19: 607.

https://www.ncbi.nlm.nih.gov/pubmed/18185903

639.Wei, J.T., et al. A midurethral sling to reduce incontinence after vaginal prolapse repair. N Engl J Med, 2012. 366: 2358.

https://www.ncbi.nlm.nih.gov/pubmed/22716974

640.van der Ploeg, J.M., et al. The predictive value of demonstrable stress incontinence during basic office evaluation and urodynamics in women without symptomatic urinary incontinence undergoing vaginal prolapse surgery. Neurourol Urodyn, 2018. 37: 1011.

https://www.ncbi.nlm.nih.gov/pubmed/28834564

641.Jelovsek, J.E., et al. A model for predicting the risk of de novo stress urinary incontinence in women undergoing pelvic organ prolapse surgery. Obstet Gynecol, 2014. 123: 279.

https://www.ncbi.nlm.nih.gov/pubmed/24402598

642.Lo, T.S., et al. Predictors for detrusor overactivity following extensive vaginal pelvic reconstructive surgery. Neurourol Urodyn, 2018. 37: 192.

https://www.ncbi.nlm.nih.gov/pubmed/28370456

643.Lo, T.S., et al. Clinical outcomes of detrusor underactivity in female with advanced pelvic organ prolapse following vaginal pelvic reconstructive surgery. Neurourol Urodyn, 2018. 37: 2242.

https://www.ncbi.nlm.nih.gov/pubmed/29664135

644.Bo, K., et al. International urogynecology consultation chapter 3 committee 2; conservative treatment of patient with pelvic organ prolapse: Pelvic floor muscle training. Int Urogynecol J, 2022. 33: 2633.

https://www.ncbi.nlm.nih.gov/pubmed/35980443

645.Stupp, L., et al. Pelvic floor muscle training for treatment of pelvic organ prolapse: an assessor-blinded randomized controlled trial. Int Urogynecol J, 2011. 22: 1233.

https://www.ncbi.nlm.nih.gov/pubmed/21484362

646.Due, U., et al. Lifestyle advice with or without pelvic floor muscle training for pelvic organ prolapse: a randomized controlled trial. Int Urogynecol J, 2016. 27: 555.

https://www.ncbi.nlm.nih.gov/pubmed/26439114

647.Due, U., et al. The 12-month effects of structured lifestyle advice and pelvic floor muscle training for pelvic organ prolapse. Acta Obstet Gynecol Scand, 2016. 95: 811.

https://www.ncbi.nlm.nih.gov/pubmed/26910261

648.Hagen, S., et al. Individualised pelvic floor muscle training in women with pelvic organ prolapse (POPPY): a multicentre randomised controlled trial. Lancet, 2014. 383: 796.

https://www.ncbi.nlm.nih.gov/pubmed/24290404

649.Hagen, S., et al. Pelvic floor muscle training for secondary prevention of pelvic organ prolapse (PREVPROL): a multicentre randomised controlled trial. Lancet, 2017. 389: 393.

https://www.ncbi.nlm.nih.gov/pubmed/28010994

650.Cheung, R.Y., et al. Vaginal Pessary in Women With Symptomatic Pelvic Organ Prolapse: A Randomized Controlled Trial. Obstet Gynecol, 2016. 128: 73.

https://www.ncbi.nlm.nih.gov/pubmed/27275798

651.Panman, C., et al. Two-year effects and cost-effectiveness of pelvic floor muscle training in mild pelvic organ prolapse: a randomised controlled trial in primary care. BJOG, 2017. 124: 511.

https://www.ncbi.nlm.nih.gov/pubmed/26996291

652.Frawley, H.C., et al. Physiotherapy as an adjunct to prolapse surgery: an assessor-blinded randomized controlled trial. Neurourol Urodyn, 2010. 29: 719.

https://www.ncbi.nlm.nih.gov/pubmed/19816918

653.Pauls, R.N., et al. Pelvic floor physical therapy: impact on quality of life 6 months after vaginal reconstructive surgery. Female Pelvic Med Reconstr Surg, 2014. 20: 334.

https://www.ncbi.nlm.nih.gov/pubmed/25185628

654.Barber, M.D., et al. Comparison of 2 transvaginal surgical approaches and perioperative behavioral therapy for apical vaginal prolapse: the OPTIMAL randomized trial. JAMA, 2014. 311: 1023.

https://www.ncbi.nlm.nih.gov/pubmed/24618964

655.Weidner, A.C., et al. Perioperative Behavioral Therapy and Pelvic Muscle Strengthening Do Not Enhance Quality of Life After Pelvic Surgery: Secondary Report of a Randomized Controlled Trial. Phys Ther, 2017. 97: 1075.

https://www.ncbi.nlm.nih.gov/pubmed/29077924

656.van der Vaart, L.R., et al. Pessary or surgery for a symptomatic pelvic organ prolapse: the PEOPLE study, a multicentre prospective cohort study. BJOG, 2022. 129: 820.

https://www.ncbi.nlm.nih.gov/pubmed/34559932

657.de Boer, T.A., et al. Predictive factors for overactive bladder symptoms after pelvic organ prolapse surgery. Int Urogynecol J, 2010. 21: 1143.

https://www.ncbi.nlm.nih.gov/pubmed/20419366

658.Kim, M.S., et al. The association of pelvic organ prolapse severity and improvement in overactive bladder symptoms after surgery for pelvic organ prolapse. Obstet Gynecol Sci, 2016. 59: 214.

https://www.ncbi.nlm.nih.gov/pubmed/27200312

659.Costantini, E., et al. Urgency, detrusor overactivity and posterior vault prolapse in women who underwent pelvic organ prolapse repair. Urol Int, 2013. 90: 168.

https://www.ncbi.nlm.nih.gov/pubmed/23327990

660.van der Ploeg, J.M., et al. Prolapse surgery with or without incontinence procedure: a systematic review and meta-analysis. BJOG, 2018. 125: 289.

https://www.ncbi.nlm.nih.gov/pubmed/28941138

661.Baessler, K., et al. Surgery for women with pelvic organ prolapse with or without stress urinary incontinence. Cochrane Database Syst Rev, 2018. 8: CD013108.

https://www.ncbi.nlm.nih.gov/pubmed/30121956

662.Borstad, E., et al. Surgical strategies for women with pelvic organ prolapse and urinary stress incontinence. Int Urogynecol J, 2010. 21: 179.

https://www.ncbi.nlm.nih.gov/pubmed/19940978

663.van der Ploeg, J.M., et al. Transvaginal prolapse repair with or without the addition of a midurethral sling in women with genital prolapse and stress urinary incontinence: a randomised trial. BJOG, 2015. 122: 1022.

https://www.ncbi.nlm.nih.gov/pubmed/25754458

664.Costantini, E., et al. Burch colposuspension does not provide any additional benefit to pelvic organ prolapse repair in patients with urinary incontinence: a randomized surgical trial. J Urol, 2008. 180: 1007.

https://www.ncbi.nlm.nih.gov/pubmed/18639302

665.Costantini, E., et al. Pelvic Organ Prolapse Repair with and without Concomitant Burch Colposuspension in Incontinent Women: A Randomised Controlled Trial with at Least 5-Year Followup. Obstet Gynecol Int, 2012. 2012: 967923.

https://www.ncbi.nlm.nih.gov/pubmed/22028719

666.Trabuco, E.C., Klingele, C.J., Occhino, J., Blandon, R.E., Mcgree, M.E., Weaver, A., Gebhart. J. 41st Annual Meeting - Cape Town, South Africa August 4 - 5, 2016. Int Urogynecol J, 2016. 27 Suppl 1: 19.

https://www.ncbi.nlm.nih.gov/pubmed/27277301

667.Sinha, A., et al. Persistent and De Novo Stress Urinary Incontinence After Minimally Invasive Sacrocolpopexy. Urogynecology (Phila), 2024.

https://www.ncbi.nlm.nih.gov/pubmed/38212891

668.Wang, R., et al. Cost Effectiveness of Concurrent Midurethral Sling at the Time of Prolapse Repair: Results From a Randomized Controlled Trial. Urogynecology (Phila), 2023. 29: 461.

https://www.ncbi.nlm.nih.gov/pubmed/36701323

669.Brubaker, L., et al. Abdominal sacrocolpopexy with Burch colposuspension to reduce urinary stress incontinence. N Engl J Med, 2006. 354: 1557.

https://www.ncbi.nlm.nih.gov/pubmed/16611949

670.Brubaker, L., et al. Two-year outcomes after sacrocolpopexy with and without burch to prevent stress urinary incontinence. Obstet Gynecol, 2008. 112: 49.

https://www.ncbi.nlm.nih.gov/pubmed/18591307

671.Meschia, M., et al. A randomized comparison of tension-free vaginal tape and endopelvic fascia plication in women with genital prolapse and occult stress urinary incontinence. Am J Obstet Gynecol, 2004. 190: 609.

https://www.ncbi.nlm.nih.gov/pubmed/15041988

672.Fuentes, A.E. A prospective randomised controlled trial comparing vaginal prolapse repair with and without tensionfree vaginal tape transobturator tape (TVTO) in women with severe genital prolapse and occult stress incontinence: long term follow up. . Int Urogynecol J, 2011. 22: Abstract 059:S60.

https://doi.org/10.1007/s00192-011-1434-z

673.Schierlitz, L., et al. Pelvic organ prolapse surgery with and without tension-free vaginal tape in women with occult or asymptomatic urodynamic stress incontinence: a randomised controlled trial. Int Urogynecol J, 2014. 25: 33.

https://www.ncbi.nlm.nih.gov/pubmed/23812579

674.van der Ploeg, J.M., et al. Vaginal prolapse repair with or without a midurethral sling in women with genital prolapse and occult stress urinary incontinence: a randomized trial. Int Urogynecol J, 2016. 27: 1029.

https://www.ncbi.nlm.nih.gov/pubmed/26740197

675.Lourenco, D.B., et al. Urodynamic profile of voiding in patients with pelvic organ prolapse after surgery: a systematic review with meta-analysis. Int Urogynecol J, 2023. 34: 53.

https://www.ncbi.nlm.nih.gov/pubmed/35460345

676.de Bernis, L. Obstetric fistula: guiding principles for clinical management and programme development, a new WHO guideline. Int J Gynaecol Obstet, 2007. 99 Suppl 1: S117.

https://www.ncbi.nlm.nih.gov/pubmed/17880979

677.Mselle, L.T., et al. Perceived Health System Causes of Obstetric Fistula from Accounts of Affected Women in Rural Tanzania: A Qualitative Study. Afr J Reprod Health, 2015. 19: 124.

https://www.ncbi.nlm.nih.gov/pubmed/26103702

678.Mwini-Nyaledzigbor, P.P., et al. Lived experiences of Ghanaian women with obstetric fistula. Health Care Women Int, 2013. 34: 440.

https://www.ncbi.nlm.nih.gov/pubmed/23641897

679.Jokhio, A.H., et al. Prevalence of obstetric fistula: a population-based study in rural Pakistan. BJOG, 2014. 121: 1039.

https://www.ncbi.nlm.nih.gov/pubmed/24684695

680.Farid, F.N., et al. Psychosocial experiences of women with vesicovaginal fistula: a qualitative approach. J Coll Physicians Surg Pak, 2013. 23: 828.

https://www.ncbi.nlm.nih.gov/pubmed/24169399

681.Imoto, A., et al. Health-related quality of life among women in rural Bangladesh after surgical repair of obstetric fistula. Int J Gynaecol Obstet, 2015. 130: 79.

https://www.ncbi.nlm.nih.gov/pubmed/25935472

682.Michel, F., et al. Epidemiology and care pathway of vesicovaginal fistulas managed in France between 2010 and 2018. World J Urol, 2022. 40: 1027.

https://www.ncbi.nlm.nih.gov/pubmed/35050406

683.Tancer, M.L. Observations on prevention and management of vesicovaginal fistula after total hysterectomy. Surg Gynecol Obstet, 1992. 175: 501.

https://www.ncbi.nlm.nih.gov/pubmed/1448730

684.Hadzi-Djokic, J., et al. Vesico-vaginal fistula: report of 220 cases. Int Urol Nephrol, 2009. 41: 299.

https://www.ncbi.nlm.nih.gov/pubmed/18810652

685.Forsgren, C., et al. Risk of pelvic organ fistula in patients undergoing hysterectomy. Curr Opin Obstet Gynecol, 2010. 22: 404.

https://www.ncbi.nlm.nih.gov/pubmed/20739885

686.Likic, I.S., et al. Analysis of urologic complications after radical hysterectomy. Am J Obstet Gynecol, 2008. 199: 644 e1.

https://www.ncbi.nlm.nih.gov/pubmed/18722569

687.Hilton, P., et al. The risk of vesicovaginal and urethrovaginal fistula after hysterectomy performed in the English National Health Service--a retrospective cohort study examining patterns of care between 2000 and 2008. BJOG, 2012. 119: 1447.

https://www.ncbi.nlm.nih.gov/pubmed/22901248

688.Liedl, B., et al. Outcomes of a bladder preservation technique in female patients undergoing pelvic exenteration surgery for advanced gynaecological tumours. Int Urogynecol J, 2014. 25: 953.

https://www.ncbi.nlm.nih.gov/pubmed/24633066

689.Kucera, H., et al. [Complications of postoperative radiotherapy in uterine cancer]. Geburtshilfe Frauenheilkd, 1984. 44: 498.

https://www.ncbi.nlm.nih.gov/pubmed/6566638

690.Biewenga, P., et al. Can we predict vesicovaginal or rectovaginal fistula formation in patients with stage IVA cervical cancer? Int J Gynecol Cancer, 2010. 20: 471.

https://www.ncbi.nlm.nih.gov/pubmed/20375815

691.Adaji, S.E., et al. Vaginally inserted herbs causing vesico-vaginal fistula and vaginal stenosis. Int Urogynecol J, 2013. 24: 1057.

https://www.ncbi.nlm.nih.gov/pubmed/22797463

692.Donaldson, J.F., et al. Obstructive uropathy and vesicovaginal fistula secondary to a retained sex toy in the vagina. J Sex Med, 2014. 11: 2595.

https://www.ncbi.nlm.nih.gov/pubmed/24919434

693.Penrose, K.J., et al. Delayed vesicovaginal fistula after ring pessary usage. Int Urogynecol J, 2014. 25: 291.

https://www.ncbi.nlm.nih.gov/pubmed/23801483

694.Huang, L.K., et al. Evaluation of the extent of ketamine-induced uropathy: the role of CT urography. Postgrad Med J, 2014. 90: 185.

https://www.ncbi.nlm.nih.gov/pubmed/24443558

695.Browning, A. Risk factors for developing residual urinary incontinence after obstetric fistula repair. BJOG, 2006. 113: 482.

https://www.ncbi.nlm.nih.gov/pubmed/16489933

696.Goh, J.T. A new classification for female genital tract fistula. Aust N Z J Obstet Gynaecol, 2004. 44: 502.

https://www.ncbi.nlm.nih.gov/pubmed/15598284

697.Goh, J.T., et al. Predicting the risk of failure of closure of obstetric fistula and residual urinary incontinence using a classification system. Int Urogynecol J Pelvic Floor Dysfunct, 2008. 19: 1659.

https://www.ncbi.nlm.nih.gov/pubmed/18690403

698.Beardmore-Gray, A., et al. Does the Goh classification predict the outcome of vesico-vaginal fistula repair in the developed world? Int Urogynecol J, 2017. 28: 937.

https://www.ncbi.nlm.nih.gov/pubmed/27822888

699.Ostrzenski, A., et al. Bladder injury during laparoscopic surgery. Obstet Gynecol Surv, 1998. 53: 175.

https://www.ncbi.nlm.nih.gov/pubmed/9513988

700.Narayanan, P., et al. Fistulas in malignant gynecologic disease: etiology, imaging, and management. Radiographics, 2009. 29: 1073.

https://www.ncbi.nlm.nih.gov/pubmed/19605657

701.Latzko, W. Postoperative vesicovaginal fistulas. The American Journal of Surgery, 1942. 58: 211.

https://doi.org/10.1016/S0002-9610(42)90009-6

702.De Ridder, D., et al., Fistula (Committee 18), in Incontinence, P. Abrams, Cardozo, L, Wagg, A, Wein, A, Editor. 2017, ICI-ICS International Continence Society: Bristol UK.

https://www.ics.org/Publications/ICI_5/INCONTINENCE.pdf

703.Rajaian, S., et al. Vesicovaginal fistula: Review and recent trends. Indian J Urol, 2019. 35: 250.

https://www.ncbi.nlm.nih.gov/pubmed/31619862

704.Yokoyama, M., et al. Successful management of vesicouterine fistula by luteinizing hormone-releasing hormone analog. Int J Urol, 2006. 13: 457.

https://www.ncbi.nlm.nih.gov/pubmed/16734874

705.Goh, J.T., et al. Oestrogen therapy in the management of vesicovaginal fistula. Aust N Z J Obstet Gynaecol, 2001. 41: 333.

https://www.ncbi.nlm.nih.gov/pubmed/11592553

706.Hemal, A.K., et al. Youssef's syndrome: an appraisal of hormonal treatment. Urol Int, 1994. 52: 55.

https://www.ncbi.nlm.nih.gov/pubmed/8140684

707.Tarhan, F., et al. Minimal invasive treatment of vesicouterine fistula: a case report. Int Urol Nephrol, 2007. 39: 791.

https://www.ncbi.nlm.nih.gov/pubmed/17006733

708.Kumar, A., et al. Management of vesico-uterine fistulae: a report of six cases. Int J Gynaecol Obstet, 1988. 26: 453.

https://www.ncbi.nlm.nih.gov/pubmed/2900177

709.Rubino, S.M. Vesico-uterine fistula treated by amenorrhoea induced with contraceptive steroids. Two case reports. Br J Obstet Gynaecol, 1980. 87: 343.

https://www.ncbi.nlm.nih.gov/pubmed/7426505

710.Jozwik, M., et al. Spontaneous closure of vesicouterine fistula. Account for effective hormonal treatment. Urol Int, 1999. 62: 183.

https://www.ncbi.nlm.nih.gov/pubmed/10529673

711.Safan, A., et al. Fibrin glue versus martius flap interpositioning in the repair of complicated obstetric vesicovaginal fistula. A prospective multi-institution randomized trial. Neurourol Urodyn, 2009. 28: 438.

https://www.ncbi.nlm.nih.gov/pubmed/19475577

712.Garrido-Ruiz, M.C., et al. Vulvar pseudoverrucous papules and nodules secondary to a urethral--vaginal fistula. Am J Dermatopathol, 2011. 33: 410.

https://www.ncbi.nlm.nih.gov/pubmed/21285858

713.Onuora, V.C., et al. Iatrogenic urogenital fistulae. Br J Urol, 1993. 71: 176.

https://www.ncbi.nlm.nih.gov/pubmed/8461950

714.El-Azab, A.S., et al. Update on vesicovaginal fistula: A systematic review. Arab J Urol, 2019. 17: 61.

https://www.ncbi.nlm.nih.gov/pubmed/31258945

715.Blaivas, J.G., et al. Early versus late repair of vesicovaginal fistulas: vaginal and abdominal approaches. J Urol, 1995. 153: 1110.

https://www.ncbi.nlm.nih.gov/pubmed/7869475

716.Wang, Y., et al. Nondelayed transvaginal repair of high lying vesicovaginal fistula. J Urol, 1990. 144: 34.

https://www.ncbi.nlm.nih.gov/pubmed/2359177

717.Wall, L.L. Dr. George Hayward (1791-1863): a forgotten pioneer of reconstructive pelvic surgery. Int Urogynecol J Pelvic Floor Dysfunct, 2005. 16: 330.

https://www.ncbi.nlm.nih.gov/pubmed/15976986

718.Hilton, P., et al. Epidemiological and surgical aspects of urogenital fistulae: a review of 25 years' experience in southeast Nigeria. Int Urogynecol J Pelvic Floor Dysfunct, 1998. 9: 189.

https://www.ncbi.nlm.nih.gov/pubmed/9795822

719.Jefferson, F.A., et al. Perioperative Outcomes of Vesicovaginal Fistula Repair by Surgical Approach. Urogynecology (Phila), 2024. 30: 114.

https://www.ncbi.nlm.nih.gov/pubmed/37493226

720.Shaker, H., et al. Obstetric vesico-vaginal fistula repair: should we trim the fistula edges? A randomized prospective study. Neurourol Urodyn, 2011. 30: 302.

https://www.ncbi.nlm.nih.gov/pubmed/21308748

721.Krause, S., et al. Surgery for urologic complications following radiotherapy for gynecologic cancer. Scand J Urol Nephrol, 1987. 21: 115.

https://www.ncbi.nlm.nih.gov/pubmed/3616502

722.Langkilde, N.C., et al. Surgical repair of vesicovaginal fistulae--a ten-year retrospective study. Scand J Urol Nephrol, 1999. 33: 100.

https://www.ncbi.nlm.nih.gov/pubmed/10360449

723.Morton, H.C., et al. Urethral injury associated with minimally invasive mid-urethral sling procedures for the treatment of stress urinary incontinence: a case series and systematic literature search. BJOG, 2009. 116: 1120.

https://www.ncbi.nlm.nih.gov/pubmed/19438488

724.Lumen, N., et al. Review of the current management of lower urinary tract injuries by the EAU Trauma Guidelines Panel. Eur Urol, 2015. 67: 925.

https://www.ncbi.nlm.nih.gov/pubmed/25576009

725.Brandes, S., et al. Diagnosis and management of ureteric injury: an evidence-based analysis. BJU Int, 2004. 94: 277.

https://www.ncbi.nlm.nih.gov/pubmed/15291852

726.Poletajew, S., et al. Kidney removal: the past, presence, and perspectives: a historical review. Urol J, 2010. 7: 215.

https://www.ncbi.nlm.nih.gov/pubmed/21170847

727.Matz, M. [Prognosis-oriented diagnosis, treatment protocol and after care in uretero-vaginal fistula following gynecological surgery from the urological viewpoint]. Zentralbl Gynakol, 1990. 112: 1345.

https://www.ncbi.nlm.nih.gov/pubmed/2278219

728.Benchekroun, A., et al. [Uretero-vaginal fistulas. 45 cases]. Ann Urol (Paris), 1998. 32: 295.

https://www.ncbi.nlm.nih.gov/pubmed/9827201

729.el Ouakdi, M., et al. [Uretero-vaginal fistula. Apropos of 30 cases]. J Gynecol Obstet Biol Reprod (Paris), 1989. 18: 891.

https://www.ncbi.nlm.nih.gov/pubmed/2614029

730.Murphy, D.M., et al. Ureterovaginal fistula: a report of 12 cases and review of the literature. J Urol, 1982. 128: 924.

https://www.ncbi.nlm.nih.gov/pubmed/7176053

731.Abou-El-Ghar, M.E., et al. Radiological diagnosis of vesicouterine fistula: role of magnetic resonance imaging. J Magn Reson Imaging, 2012. 36: 438.

https://www.ncbi.nlm.nih.gov/pubmed/22535687

732.Quiroz, L.H., et al. Three-dimensional ultrasound imaging for diagnosis of urethrovaginal fistula. Int Urogynecol J, 2010. 21: 1031.

https://www.ncbi.nlm.nih.gov/pubmed/20069418

733.Goodwin, W.E., et al. Vesicovaginal and ureterovaginal fistulas: a summary of 25 years of experience. J Urol, 1980. 123: 370.

https://www.ncbi.nlm.nih.gov/pubmed/7359641

734.Pushkar, D.Y., et al. Management of urethrovaginal fistulas. Eur Urol, 2006. 50: 1000.

https://www.ncbi.nlm.nih.gov/pubmed/16945476

735.Pushkar, D. Editorial comment on: Transpubic access using pedicle tubularized labial urethroplasty for the treatment of female urethral strictures associated with urethrovaginal fistulas secondary to pelvic fracture. Eur Urol, 2009. 56: 200.

https://www.ncbi.nlm.nih.gov/pubmed/18468776

736.Xu, Y.M., et al. Transpubic access using pedicle tubularized labial urethroplasty for the treatment of female urethral strictures associated with urethrovaginal fistulas secondary to pelvic fracture. Eur Urol, 2009. 56: 193.

https://www.ncbi.nlm.nih.gov/pubmed/18468778

737.Huang, C.R., et al. The management of old urethral injury in young girls: analysis of 44 cases. J Pediatr Surg, 2003. 38: 1329.

https://www.ncbi.nlm.nih.gov/pubmed/14523814

738.Browning, A. Lack of value of the Martius fibrofatty graft in obstetric fistula repair. Int J Gynaecol Obstet, 2006. 93: 33.

https://www.ncbi.nlm.nih.gov/pubmed/16530766

739.Baskin, D., et al. Martius repair in urethrovaginal defects. J Pediatr Surg, 2005. 40: 1489.

https://www.ncbi.nlm.nih.gov/pubmed/16150356

740.Atan, A., et al. Treatment of refractory urethrovaginal fistula using rectus abdominis muscle flap in a six-year-old girl. Urology, 2007. 69: 384 e11.

https://www.ncbi.nlm.nih.gov/pubmed/17320687

741.Bruce, R.G., et al. Use of rectus abdominis muscle flap for the treatment of complex and refractory urethrovaginal fistulas. J Urol, 2000. 163: 1212.

https://www.ncbi.nlm.nih.gov/pubmed/10737499

742.Koraitim, M. A new retropubic retrourethral approach for large vesico-urethrovaginal fistulas. J Urol, 1985. 134: 1122.

https://www.ncbi.nlm.nih.gov/pubmed/4057401

743.Rovner, E.S. Urethral diverticula: a review and an update. Neurourol Urodyn, 2007. 26: 972.

https://www.ncbi.nlm.nih.gov/pubmed/17654566

744.Crescenze, I.M., et al. Female Urethral Diverticulum: Current Diagnosis and Management. Curr Urol Rep, 2015. 16: 71.

https://www.ncbi.nlm.nih.gov/pubmed/26267225

745.El-Nashar, S.A., et al. Incidence of female urethral diverticulum: a population-based analysis and literature review. Int Urogynecol J, 2014. 25: 73.

https://www.ncbi.nlm.nih.gov/pubmed/23857063

746.Adelowo, A., et al. The role of preoperative urodynamics in urogynecologic procedures. J Minim Invasive Gynecol, 2014. 21: 217.

https://www.ncbi.nlm.nih.gov/pubmed/24144925

747.Reeves, F.A., et al. Management of symptomatic urethral diverticula in women: a single-centre experience. Eur Urol, 2014. 66: 164.

https://www.ncbi.nlm.nih.gov/pubmed/24636677

748.Athanasopoulos, A., et al. Urethral diverticulum: a new complication associated with tension-free vaginal tape. Urol Int, 2008. 81: 480.

https://www.ncbi.nlm.nih.gov/pubmed/19077415

749.Hammad, F.T. TVT can also cause urethral diverticulum. Int Urogynecol J Pelvic Floor Dysfunct, 2007. 18: 467.

https://www.ncbi.nlm.nih.gov/pubmed/16821000

750.Mahdy, A., et al. Urethral diverticulum after tension-free vaginal tape procedure: case report. Urology, 2008. 72: 461 e5.

https://www.ncbi.nlm.nih.gov/pubmed/18355901

751.Han, D.H., et al. Outcomes of surgery of female urethral diverticula classified using magnetic resonance imaging. Eur Urol, 2007. 51: 1664.

https://www.ncbi.nlm.nih.gov/pubmed/17335961

752.Leach, G.E., et al. L N S C3: a proposed classification system for female urethral diverticula. Neurourol Urodyn, 1993. 12: 523.

https://www.ncbi.nlm.nih.gov/pubmed/8312937

753.Cameron, A.P. Urethral diverticulum in the female: a meta-analysis of modern series. Minerva Ginecol, 2016. 68: 186.

https://www.ncbi.nlm.nih.gov/pubmed/26545036

754.Barakat, B., et al. Correlation between symptoms and imaging findings including pelvic floor ultrasound to improve the symptom-based diagnosis of female urethral diverticulum (CHECK-UD study). Int Urogynecol J, 2022. 33: 2267.

https://www.ncbi.nlm.nih.gov/pubmed/33871666

755.Blander, D.S., et al. Endoluminal magnetic resonance imaging in the evaluation of urethral diverticula in women. Urology, 2001. 57: 660.

https://www.ncbi.nlm.nih.gov/pubmed/11306374

756.Pathi, S.D., et al. Utility of clinical parameters, cystourethroscopy, and magnetic resonance imaging in the preoperative diagnosis of urethral diverticula. Int Urogynecol J, 2013. 24: 319.

https://www.ncbi.nlm.nih.gov/pubmed/22707007

757.Dwarkasing, R.S., et al. MRI evaluation of urethral diverticula and differential diagnosis in symptomatic women. AJR Am J Roentgenol, 2011. 197: 676.

https://www.ncbi.nlm.nih.gov/pubmed/21862811

758.Chung, D.E., et al. Urethral diverticula in women: discrepancies between magnetic resonance imaging and surgical findings. J Urol, 2010. 183: 2265.

https://www.ncbi.nlm.nih.gov/pubmed/20400161

759.Akinjise-Ferdinand, O., et al. A diagnostic conundrum: Is it a periurethral diverticulum/cyst or a bulking agent (Bulkamid)? Neurourol Urodyn, 2023. 42: 547.

https://www.ncbi.nlm.nih.gov/pubmed/36285552

760.Khati, N.J., et al. MR imaging diagnosis of a urethral diverticulum. Radiographics, 1998. 18: 517.

https://www.ncbi.nlm.nih.gov/pubmed/9536494

761.Rovner, E.S., et al. Diagnosis and reconstruction of the dorsal or circumferential urethral diverticulum. J Urol, 2003. 170: 82.

https://www.ncbi.nlm.nih.gov/pubmed/12796650

762.Chou, C.P., et al. Imaging of female urethral diverticulum: an update. Radiographics, 2008. 28: 1917.

https://www.ncbi.nlm.nih.gov/pubmed/19001648

763.Baradaran, N., et al. Female Urethral Diverticula in the Contemporary Era: Is the Classic Triad of the "3Ds" Still Relevant? Urology, 2016. 94: 53.

https://www.ncbi.nlm.nih.gov/pubmed/27079128

764.Stav, K., et al. Urinary symptoms before and after female urethral diverticulectomy--can we predict de novo stress urinary incontinence? J Urol, 2008. 180: 2088.

https://www.ncbi.nlm.nih.gov/pubmed/18804229

765.Ockrim, J.L., et al. A tertiary experience of urethral diverticulectomy: diagnosis, imaging and surgical outcomes. BJU Int, 2009. 103: 1550.

https://www.ncbi.nlm.nih.gov/pubmed/19191783

766.Bhatia, N.N., et al. Urethral pressure profiles of women with urethral diverticula. Obstet Gynecol, 1981. 58: 375.

https://www.ncbi.nlm.nih.gov/pubmed/7196559

767.Reid, R.E., et al. Role of urodynamics in management of urethral diverticulum in females. Urology, 1986. 28: 342.

https://www.ncbi.nlm.nih.gov/pubmed/3094219

768.Summitt, R.L., Jr., et al. Urethral diverticula: evaluation by urethral pressure profilometry, cystourethroscopy, and the voiding cystourethrogram. Obstet Gynecol, 1992. 80: 695.

https://www.ncbi.nlm.nih.gov/pubmed/1407897

769.Bass, J.S., et al. Surgical treatment of concomitant urethral diverticulum and stress incontinence. Urol Clin North Am, 1991. 18: 365.

https://www.ncbi.nlm.nih.gov/pubmed/1902010

770.Ganabathi, K., et al. Experience with the management of urethral diverticulum in 63 women. J Urol, 1994. 152: 1445.

https://www.ncbi.nlm.nih.gov/pubmed/7933181

771.Wagner, U., et al. [Significance of the urethral pressure profile in the diagnosis of urethral diverticulum]. Geburtshilfe Frauenheilkd, 1986. 46: 456.

https://www.ncbi.nlm.nih.gov/pubmed/3093308

772.Thomas, A.A., et al. Urethral diverticula in 90 female patients: a study with emphasis on neoplastic alterations. J Urol, 2008. 180: 2463.

https://www.ncbi.nlm.nih.gov/pubmed/18930487

773.Greiman, A.K., et al. Urethral diverticulum: A systematic review. Arab J Urol, 2019. 17: 49.

https://www.ncbi.nlm.nih.gov/pubmed/31258943

774.Merriman, A.L., et al. Patients' Perspectives: Outcomes of Modified Marsupialization for Treatment of Female Urethral Diverticula. Urogynecology (Phila), 2023. 29: 452.

https://www.ncbi.nlm.nih.gov/pubmed/36730945

775.Chang, Y.L., et al. Presentation of female urethral diverticulum is usually not typical. Urol Int, 2008. 80: 41.

https://www.ncbi.nlm.nih.gov/pubmed/18204232

776.Ljungqvist, L., et al. Female urethral diverticulum: 26-year followup of a large series. J Urol, 2007. 177: 219.

https://www.ncbi.nlm.nih.gov/pubmed/17162049

777.Enemchukwu, E., et al. Autologous Pubovaginal Sling for the Treatment of Concomitant Female Urethral Diverticula and Stress Urinary Incontinence. Urology, 2015. 85: 1300.

https://www.ncbi.nlm.nih.gov/pubmed/26099875

778.Faerber, G.J. Urethral diverticulectomy and pubovaginal sling for simultaneous treatment of urethral diverticulum and intrinsic sphincter deficiency. Tech Urol, 1998. 4: 192.

https://www.ncbi.nlm.nih.gov/pubmed/9892000

779.Romanzi, L.J., et al. Urethral diverticulum in women: diverse presentations resulting in diagnostic delay and mismanagement. J Urol, 2000. 164: 428.

https://www.ncbi.nlm.nih.gov/pubmed/10893602

780.Swierzewski, S.J., 3rd, et al. Pubovaginal sling for treatment of female stress urinary incontinence complicated by urethral diverticulum. J Urol, 1993. 149: 1012.

https://www.ncbi.nlm.nih.gov/pubmed/8483202

781.Dmochowski, R.R., et al. Update of AUA guideline on the surgical management of female stress urinary incontinence. J Urol, 2010. 183: 1906.

https://www.ncbi.nlm.nih.gov/pubmed/20303102

782.Nickles, S.W., et al. Simple vs complex urethral diverticulum: presentation and outcomes. Urology, 2014. 84: 1516.

https://www.ncbi.nlm.nih.gov/pubmed/25432847

783.Bodner-Adler, B., et al. Surgical management of urethral diverticula in women: a systematic review. Int Urogynecol J, 2016. 27: 993.

https://www.ncbi.nlm.nih.gov/pubmed/26564222

784.Ingber, M.S., et al. Surgically corrected urethral diverticula: long-term voiding dysfunction and reoperation rates. Urology, 2011. 77: 65.

https://www.ncbi.nlm.nih.gov/pubmed/20800882

785.Lee, U.J., et al. Rate of de novo stress urinary incontinence after urethal diverticulum repair. Urology, 2008. 71: 849.

https://www.ncbi.nlm.nih.gov/pubmed/18355904

786.Rovner, E. Bladder and Female Urethral Diverticula. 2020.

https://abdominalkey.com/bladder-and-female-urethral-diverticula/

787.Laudano, M.A., et al. Pathologic Outcomes following Urethral Diverticulectomy in Women. Adv Urol, 2014. 2014: 861940.

https://www.ncbi.nlm.nih.gov/pubmed/24860605

788.Tsivian, M., et al. Female urethral diverticulum: a pathological insight. Int Urogynecol J Pelvic Floor Dysfunct, 2009. 20: 957.

https://www.ncbi.nlm.nih.gov/pubmed/19582385

789.Thomas, R.B., et al. Adenocarcinoma in a female urethral diverticulum. Aust N Z J Surg, 1991. 61: 869.

https://www.ncbi.nlm.nih.gov/pubmed/1750825

About EAU
  • Who we are
  • How we work
  • Become a member
Services
  • MyEAU
  • Congress registrations
  • Abstract submission
Media
  • EAU News
  • EAU Newsletter
  • EAU Press Releases
Contact
  • EAU Central Office
    PO Box 30016
    NL-6803 AA ARNHEM
    The Netherlands

  • Contact us
About EAU
Who we areHow we workBecome a member
Services
MyEAUCongress registrationsAbstract submission
Media
EAU NewsEAU NewsletterEAU Press Releases
Contact

EAU Central Office
PO Box 30016
NL-6803 AA ARNHEM
The Netherlands

Contact us
European Association of Urology
Privacy PolicyDisclaimer